<!--#if expr="$title" --> <!--#echo var="title" --> <!--#else --> HIV Drug Resistance Database <!--#endif -->
Stanford University HIV Drug Resistance Database - A curated public database designed to represent, store, and analyze the divergent forms of data underlying HIV drug resistance.

Genbank References

BLAST search against GenBank file v. V 200.0 released on 2014-02-15
(search results include 202208 sequences from 2103 references)

This page contains a list of all GenBank entries on HIV-1 protease, RT and integrase grouped by reference. The reference may include a published paper or the title provided with the GenBank submission. The purpose of this page is to show which GenBank entries are in the HIV Drug Resistance Database and which aren't. The last column (Annotation) of the table shows whether or not there are plans to add the entry to the database. Each entry in the Annotation column is linked to a page explaining the annotation.

The entries were created by performing a BLAST search of the GenBank using the consensus B protease, RT and integrase amino acid sequence (give link to the sequences). The E-value column contains the lowest e-value (best match) for all the GenBank entries associated with a specific reference. The columns, # in GB, # in HIVDB, and % in HIVDB indicate the number of entries in GenBank associated with the reference, the number of these entries that are also in the HIV Drug Resistance Database, and the % of GenBank entries from a particular reference that are in the HIV Drug Resistance Database.

For a treatment summary for every isolate in our database and in the GenBank, click here. This file indicates whether or not the person from whom the sequenced virus was obtained had received one or more nucleoside RT inhibitor, nonnucleoside RT inhibitor, or protease inhibitor.


 

AuthorsTitleCitationE-value# in HIVDB# in Gb% in HIVDBAnnotation
Abecasis (2007) RECOMBINATION confounds the early evolutionary history of human immunodeficiency virus type 1: subtype g is a circulating recombinant form J. Virol. 81 (16), 8543-8551 (2007) 0 1
1PR
1RT
1IN
1
1RT
1IN
100 HIVDB
Abecasis (2011) Molecular epidemiological analysis of paired pol/env sequences from portuguese HIV-1 patients AIDS Res. Hum. Retroviruses (2011) In press 0  
154
18PR
154RT
0 ARV Rx and/or other data are N/A
Acharya (2009) Human immunodeficiency virus type 1 drug resistance mutations in patients from India Unpublished 1e-178  
1
1RT
0 Unpublished
Achkar (2004) INFECTION with group M non-B HIV-1 subtypes in individuals living in New York City Unpublished 1e-159  
34
34PR
3RT
0 ARV Rx and/or other data are N/A
Adachi (1986) PRODUCTION of acquired immunodeficiency syndrome-associated retrovirus in human and nonhuman cells transfected with an infectious molecular clone J. Virol. 59 (2), 284-291 (1986) 1e-165  
1PR
1RT
1IN
1
1PR
1RT
1IN
0 Laboratory/experimental isolate
Adojaan (2004) PREDOMINANCE of a Rare Type of HIV-1 in Estonia J. Acquir. Immune Defic. Syndr. 39 (5), 598-605 (2005) 0 4
4PR
4RT
4IN
143
142PR
4RT
4IN
2 HIVDB
Afonso (2012) HIV-1 Genetic Diversity and Transmitted Drug Resistance Mutations among Patients from the North, Central and South Regions of Angola PLoS ONE 7 (8), E42996 (2012) 2e-178 95
94PR
95RT
95
95RT
100 HIVDB
Aghokeng (2007) FULL-LENGTH sequence analysis of SIVmus in wild populations of mustached monkeys (Cercopithecus cephus) from Cameroon provides evidence for two co-circulating SIVmus lineages Virology 360 (2), 407-418 (2007) 0 5
3PR
5RT
5IN
5
5RT
5IN
100 HIVDB
Aghokeng (2009) Evaluation of transmitted HIV drug resistance among recently-infected antenatal clinic attendees in four Central African countries Antivir. Ther. (Lond.) 14 (3), 401-411 (2009) 0 135
135PR
135RT
135
3PR
135RT
100 HIVDB
Aghokeng (2010) Extensive survey on the prevalence and genetic diversity of SIVs in primate bushmeat provides insights into risks for potential new cross-species transmissions Infect. Genet. Evol. (2009) In press 0  
20
2RT
20IN
0 Pending
Aghokeng (2010) Genetic diversity of simian lentivirus in wild De Brazza's monkeys (Cercopithecus neglectus) in Equatorial Africa J. Gen. Virol. 91 (PT 7), 1810-1816 (2010) 2e-70  
1
1IN
0 Pending
Aghokeng (2011) High Failure Rate of the ViroSeq HIV-1 Genotyping System for Drug Resistance Testing in Cameroon, a Country with Broad HIV-1 Genetic Diversity J. Clin. Microbiol. 49 (4), 1635-1641 (2011) 1e-176 145
145PR
145RT
145
22PR
145RT
100 HIVDB
Aghokeng (2011) Scale-up of antiretroviral treatment in sub-Saharan Africa is accompanied by increasing HIV-1 drug resistance mutations in drug-naive patients AIDS 25 (17), 2183-2188 (2011) 0 85
85PR
85RT
85
7PR
85RT
100 HIVDB
Aghokeng (2013) Virological outcome and patterns of HIV-1 drug resistance in patients with 36 months' antiretroviral therapy experience in Cameroon J Int AIDS Soc 16, 18004 (2013) 0 65
65PR
65RT
65
3PR
65RT
100 HIVDB
Agneskog (2008) CHANGES in mutation patterns of a mosaic genome HIV-1 strain after treatment with nucleoside analogs and the integrase inhibitor raltegravir Unpublished 1e-173  
4
2RT
2IN
0 Pending
Agwale (2003) GENOTYPIC and phenotypic analyses of human immunodeficiency virus type 1 in antiretroviral drug-naive nigerian patients AIDS Res. Hum. Retroviruses 22 (1), 22-26 (2006) 5e-81 18
18PR
18RT
18
18PR
18RT
100 HIVDB
Agwu (2008) Analyses of HIV-1 Drug-Resistance Profiles Among Infected Adolescents Experiencing Delayed Antiretroviral Treatment Switch Following Initial Nonsuppressive Highly Active Antiretroviral Therapy Unpublished 1e-155  
155
146PR
31RT
0 Pending
Agyingi (2014) The Evolution of HIV-1 group M Genetic Variability in Southern Cameroon is characterized by Several Emerging Recombinant Forms of CRF02_AG and viruses with drug resistance mutations Unpublished 0  
90
90RT
0 Pending
Ahuka-Mundeke (2010) Full-length genome sequence of a simian immunodeficiency virus (SIV) infecting a captive agile mangabey (Cercocebus agilis) is closely related to SIVrcm infecting wild red-capped mangabeys (Cercocebus torquatus) in Cameroon. J Gen Virol 0 2
2PR
2RT
2IN
2
2RT
2IN
100 HIVDB
Ahuka-Mundeke (2011) Novel Multiplexed HIV/Simian Immunodefi ciency Virus Antibody Detection Assay Emerging Infect. Dis. 17 (12), 2277-2286 (2011) 4e-65  
7
7IN
0 Gene fragment(s)
Ahumada-Ruiz (2009) Analysis of HIV-1 pol sequences from Panama: identification of phylogenetic clusters within subtype B and detection of antiretroviral drug resistance mutations Infect. Genet. Evol. 9 (5), 933-940 (2009) 0  
136
80PR
135RT
0 Pending
Ajoge (2011) Drug resistance pattern of HIV type 1 isolates sampled in 2007 from therapy-naive pregnant women in North-Central Nigeria AIDS Res. Hum. Retroviruses 28 (1), 115-118 (2012) 0 53
25PR
28RT
53
25PR
28RT
100 HIVDB
Akapirat (2013) Clinical variables influencing anti-human immunodeficiency virus type 1 neutralizing human monoclonal antibody (NHMAb) production from Thai human immunodeficiency virus type 1-infected individuals Unpublished 3e-58  
2
2PR
0 Pending
Akrim (2012) HIV-1 Subtype distribution in morocco based on national sentinel surveillance data 2004-2005 AIDS Res Ther 9 (1), 5 (2012) 5e-61 56
56PR
56
56PR
100 HIVDB
Albert (1992) PERSISTENCE of azidothymidine-resistant human immunodeficiency virus type 1 RNA genotypes in posttreatment sera J. Virol. 66 (9), 5627-5630 (1992) 5e-55  
20
20RT
0 Case report(s) / study subset
Alcalde (2011) Clinical, epidemiological and molecular features of the HIV-1 subtype C and recombinant forms that are circulating in the city of Sao Paulo, Brazil Virol. J. 9, 156 (2012) 0 45
45PR
45RT
192
141PR
79RT
23 HIVDB
Alcantara (2012) HIV-1 mother-to-child transmission and drug resistance among Brazilian pregnant women with high access to diagnosis and prophylactic measures J. Clin. Virol. 54 (1), 15-20 (2012) 1e-51 44
44PR
44RT
44
44PR
100 HIVDB
Alcantara (2012) Direct Submission Submitted (13-JUN-2011) Immunology, Federal Univer 4e-59 27
27PR
27RT
27
27PR
100 HIVDB
Alcantara (2013) Increasing heterosexual transmission of HIV-1 subtype C in Inland Central Western Brazil J. Med. Virol. 85 (3), 396-404 (2013) 4e-170 18
18PR
18RT
20
19PR
3RT
90 HIVDB
Alcantara (2013) HIV-1 mother-to-child transmission and drug resistance among Brazilian pregnant women with high access to diagnosis and prophylactic measures J. Clin. Virol. 54 (1), 15-20 (2012) 2e-171 24
24PR
24RT
24
23PR
3RT
100 HIVDB
Alencar (2012) Prevalence of genotypes and primary drug resistance among HIV+ Brazilian blood donors Unpublished 0 241
241PR
241RT
266
243PR
64RT
90 HIVDB
Alexander (2002) INHIBITION of Human Immunodeficiency Virus Type 1 (HIV-1) Replication by a Two-Amino-Acid Insertion in HIV-1 Vif from a Nonprogressing Mother and Child J. Virol. 76 (20), 10533-10539 (2002) 0.027  
1
1IN
0 Gene fragment(s)
Ali (2010) Structure-based design, synthesis, and structure-activity relationship studies of HIV-1 protease inhibitors incorporating phenyloxazolidinones J. Med. Chem. 53 (21), 7699-7708 (2010) 1e-166  
6
3PR
4RT
0 Laboratory/experimental isolate
Alizon (1986) GENETIC variability of the AIDS virus: nucleotide sequence analysis of two isolates from African patients Cell 46 (1), 63-74 (1986) 1e-165 2
1PR
1RT
2IN
2
2PR
2RT
2IN
100 HIVDB
Allan (1993) SPECIES-SPECIFIC diversity among simian immunodeficiency viruses from African green monkeys J. Virol. 65 (6), 2816-2828 (1991) 2e-33  
8
8IN
0 Laboratory/experimental isolate
Allen (2005) SELECTIVE Escape from CD8+ T-Cell Responses Represents a Major Driving Force of Human Immunodeficiency Virus Type 1 (HIV-1) Sequence Diversity and Reveals Constraints on HIV-1 Evolution J. Virol. 79 (21), 13239-13249 (2005) 0  
14
14PR
14RT
14IN
0 Evolution/quasispecies study
Altfeld (2003) HIV-1 superinfection despite broad CD8+ T-cell responses containing replication of the primary virus Nature 420 (6914), 434-439 (2002) 0  
2
2PR
2RT
0 Case report(s) / study subset
Amoedo (2011) Expression of APOBEC3G/3F and G-to-A Hypermutation Levels in HIV-1-Infected Children with Different Profiles of Disease Progression PLoS ONE 6 (8), E24118 (2011) 1e-60  
161
161PR
0 Evolution/quasispecies study
An (2012) Reconstituting the epidemic history of CRF01_AE among MSM in Liaoning, northeastern China: Implication in expanding MSM epidemic in China J. Virol. (2012) In press 0 39
39PR
39RT
39IN
39
13PR
39RT
39IN
100 HIVDB
Anderson (2000) TESTING the hypothesis of a recombinant origin of human immunodeficiency virus type 1 subtype E J. Virol. 74 (22), 10752-10765 (2000) 1e-164 4
4PR
4RT
4IN
4
4PR
4RT
4IN
100 HIVDB
Anderson (1993) ANALYSIS of envelope changes acquired by SIVmac239 during neuroadaption in rhesus macaques Virology 195 (2), 616-626 (1993) 5e-99  
1
1PR
1RT
1IN
0 Laboratory/experimental isolate
Andersson (1999) MOLECULAR characterization of HIV-1 and HIV-2 in individuals from Guinea-Bissau with single or dual infections: predominance of a distinct HIV-1 subtype A/G recombinant in West Africa Virology 261 (1999) In press 2e-66 7
7RT
7
7RT
100 HIVDB
Andreani (2008) CLINICAL evolution and antiretroviral resistance patterns in HIV-1 dual infected patients in Argentina Unpublished 1e-151  
116
100PR
51RT
0 Evolution/quasispecies study
Andreotti (2009) Comparison of HIV type 1 sequences from plasma, cell-free breast milk, and cell-associated breast milk viral populations in treated and untreated women in Mozambique AIDS Res. Hum. Retroviruses 25 (7), 707-711 (2009) 8e-59  
87
87PR
0 Evolution/quasispecies study
Andresen (2007) CHARACTERIZATION of Near Full-Length Genomes of HIV Type 1 Strains in Denmark: Basis for a Universal Therapeutic Vaccine AIDS Res. Hum. Retroviruses 23 (11), 1442-1448 (2007) 0 17
17PR
17RT
17IN
17
13PR
17RT
17IN
100 HIVDB
Annaz (2011) Presence of drug resistance mutations among drug-naive patients in morocco AIDS Res. Hum. Retroviruses 27 (8), 917-920 (2011) 2e-173 50
31PR
19RT
50
31PR
19RT
100 HIVDB
Anta (2010) Identification of a new HIV-1 circulating recombinant form in Spain Unpublished 0  
4
4RT
0 Unpublished
Anton (2004) GENOTYPIC Resistance to Efavirenz/Protease Inhibitor Regimens Unpublished 0  
219
219PR
219RT
0 ARV Rx and/or other data are N/A
Antoniadou (2013) Molecular Epidemiology of HIV Type 1 Infection in Northern Greece (2009-2010): Evidence of a Transmission Cluster of HIV Type 1 Subtype A1 Drug-Resistant Strains Among Men Who Have Sex with Men AIDS Res. Hum. Retroviruses (2013) In press 7e-64 91
91PR
91
91PR
100 HIVDB
Apetrei (1998) HUMAN immunodeficiency virus type 1 subtype F reverse transcriptase sequence and drug susceptibility J. Virol. 72 (5), 3534-3538 (1998) 1e-77 14
14RT
14
14RT
100 HIVDB
Apetrei (2003) HIV type 1 diversity in Northeastern Romania in 2000-2001 based on phylogenetic analysis of pol sequences from patients failing antiretroviral therapy AIDS Res. Hum. Retroviruses 19 (12), 1155-1161 (2003) 1e-117 163
77PR
86RT
163
77PR
86RT
100 HIVDB
Apetrei (2004) DIRECT Inoculation of Simian Immunodeficiency Virus from Sooty Mangabeys in Black Mangabeys (Lophocebus aterrimus): First Evidence of AIDS in a Heterologous African Species and Different Pathologic Outcomes of Experimental Infection J. Virol. 78 (21), 11506-11518 (2004) 4e-71  
18
18IN
0 Laboratory/experimental isolate
Apetrei (2005) MOLECULAR Epidemiology of Simian Immunodeficiency Virus SIVsm in U.S. Primate Centers Unravels the Origin of SIVmac and SIVstm J. Virol. 79 (14), 8991-9005 (2005) 4e-90 47
47IN
47
47IN
100 HIVDB
Apetrei (2006) POTENTIAL for HIV transmission through unsafe injections AIDS 20 (7), 1074-1076 (2006) 1e-148  
21
17PR
13RT
0 ARV Rx and/or other data are N/A
Apetrei (2006) Potential for HIV transmission through unsafe injections AIDS 20 (7), 1074-1076 (2006) 2e-58  
5
5PR
0 Gene fragment(s)
Apetrei (2007) SIVSMM Subtypes Induce Specific Immunologic and Virologic Changes in Naturally-Infected Sooty Mangabeys Unpublished 3e-70  
96
96IN
0 Pending
Arien (2005) REPLICATIVE fitness of historical and recent HIV-1 isolates suggests HIV-1 attenuation over time AIDS 19 (15), 1555-1564 (2005) 0 23
23PR
23RT
23
23RT
100 HIVDB
Armenia (2011) Study of Genotypic and Phenotypic HIV-1 Dynamics of Integrase Mutations During Raltegravir Treatment: A Refined Analysis by Ultra-Deep 454 Pyrosequencing J Infect Dis (2012) 1e-168 40
40IN
40
40IN
100 HIVDB
Arnold (1995) AT least five HIV-1 sequence subtypes (A, B, C, D, A/E) occur in England AIDS Res. Hum. Retroviruses 11 (3), 427-429 (1995) 1e-126  
4
4PR
0 Case report(s) / study subset
Arroyo (2004) HIV Type 1 Subtypes among Blood Donors in the Mbeya Region of Southwest Tanzania AIDS Res. Hum. Retroviruses 20 (8), 895-901 (2004) 0 20
20PR
20RT
20IN
20
20PR
20RT
20IN
100 HIVDB
Arroyo (2006) HIV-1 diversity and prevalence differ between urban and rural areas in the Mbeya region of Tanzania AIDS 19 (14), 1517-1524 (2005) 0 14
14PR
14RT
14IN
14
8PR
14RT
14IN
100 HIVDB
Arruda (2012) Short communication: intermediate prevalence of HIV type 1 primary antiretroviral resistance in Ceara State, Northeast Brazil AIDS Res. Hum. Retroviruses 27 (2), 153-156 (2011) 4e-61 65
65PR
65
65PR
100 HIVDB
Arruda (2009) Genetic diversity on the integrase region of the pol gene among HIV-1-infected patients naive for integrase inhibitors in Sao Paulo city, Brazil AIDS Res. Hum. Retroviruses 26, 1 (2010) 1e-168 76
76IN
76
76IN
100 HIVDB
Arruda (2010) Differences in frequencies of pi-resistance mutations from HIV-1 of different subtypes (B, C and F) in a cohort of patients failing arv therapy Unpublished 0  
884
256PR
791RT
0 Pending
Atkinson (2000) CORRELATION between human immunodeficiency virus genotypic resistance and virologic response in patients receiving nelfinavir monotherapy or nelfinavir with lamivudine and zidovudine J. Infect. Dis. 182 (2), 420-427 (2000) 1e-123 49
49PR
78
50PR
28RT
62 HIVDB
Aulicino (2004) CIRCULATION of novel HIV type 1 A, B/C, and F subtypes in Argentina AIDS Res. Hum. Retroviruses 21 (2), 158-164 (2005) 0 1
1PR
1RT
1IN
3
2PR
3RT
1IN
33 HIVDB
Aulicino (2005) SEQUENCE Analysis of a South American HIV Type 1 BC Recombinant AIDS Res. Hum. Retroviruses 21 (10), 894-896 (2005) 0 1
1PR
1RT
1IN
1
1RT
1IN
100 HIVDB
Aulicino (2009) HIV-1 non-nucleoside resistance mutations K103N + L100I are strongly associated with nucleoside resistance mutation L74V in BF recombinants from Argentine children under treatment failure, and reduce susceptibility to Etravirine Antivir Ther. 2010;15(4):641-50 3e-52 8
8PR
8RT
8
8PR
100 HIVDB
Aulicino (2010) HIV type-1 genotypic resistance profiles in vertically infected patients from Argentina reveal an association between K103N+L100I and L74V mutations Antivir. Ther. (Lond.) 15 (4), 641-650 (2010) 1e-57 6
6PR
6RT
6
6PR
100 HIVDB
Aulicino (2013) Longitudinal analysis of HIV-1 BF1 recombinant strains in vertically infected children from Argentina reveals a decrease in CRF12_BF pol gene mosaic patterns and high diversity of BF unique recombinant forms Infect. Genet. Evol. 11 (2), 349-357 (2011) 8e-59 23
23PR
23RT
23
23PR
100 HIVDB
Auswinporn (2001) GENOTYPIC subtyping of the HIV-1 polymerase gene in 30 naave patients from Thailand Southeast Asian J. Trop. Med. Public Health 32 (2), 346-350 1e-121 6
6PR
6RT
27
27PR
27RT
22 HIVDB
Auwanit (2001) FULL-LENGTH sequences of two CRF01_ae (subtype e) HIV type 1 isolates from 1995 samples of patients with sexually transmitted diseases in Thailand AIDS Res. Hum. Retroviruses 17 (9), 867-871 (2001) 1e-165  
2
2PR
2RT
2IN
0 Case report(s) / study subset
Auwanit (2009) Detection of drug resistance-associated and background mutations in human immunodeficiency virus type 1 CRF01_AE protease and reverse transcriptase derived from drug treatment-naive patients residing in central Thailand AIDS Res. Hum. Retroviruses 25 (6), 625-631 (2009) 4e-173 108
59PR
49RT
188
139PR
49RT
57 HIVDB
Avi (2009) Emerging transmitted drug resistance in treatment-naive human immunodeficiency virus-1 CRF06_cpx-infected patients in Estonia. Scand J Infect Dis 1e-144 55
55PR
55RT
55
55RT
100 HIVDB
Avi (2009) Characterization of integrase region polymorphisms in HIV type 1 CRF06_cpx viruses in treatment-naive patients in Estonia. ARHR 1e-164 112
112IN
114
114IN
98 HIVDB
Avi (2009) Prevalence of Drug Resistance Mutations of Human Immunodeficiency Virus - 1 CRF06_cpx in Treatment-Naive Patients in Estonia in 2008 Unpublished 4e-172 88
88PR
88RT
88
88RT
100 HIVDB
Avi (2009) Absence of genotypic drug resistance and presence of several naturally occurring polymorphisms of human immunodeficiency virus-1 CRF06_cpx in treatment-naive patients in Estonia J. Med. Virol. 81 (6), 953-958 (2009) 7e-57 2
2PR
2
2PR
100 HIVDB
Avi (2012) Transmitted Drug Resistance in Estonia in 2010 Unpublished 1e-169 17
17PR
17RT
17
1PR
17RT
100 HIVDB
Avidor (2013) Transmission Patterns of HIV-Subtypes A/AE versus B: Inferring Risk-Behavior Trends and Treatment-Efficacy Limitations from Viral Genotypic Data Obtained Prior to and during Antiretroviral Therapy PLoS ONE 8 (3), E57789 (2013) 2e-57 3
3PR
3RT
45
45PR
6 HIVDB
Avila-Rios (2013) National Prevalence and Trends of HIV Transmitted Drug Resistance in Mexico PLoS ONE 6 (11), E27812 (2011) 0 1639
1639PR
1639RT
1639
1059PR
1639RT
100 HIVDB
AYEHUMIE (1991) Human immunodeficiency virus type 1 proviral DNA Unpublished (1991) 4e-41  
8
8PR
0 Gene fragment(s)
Ayouba (2009) Low prevalence of HIV type 1 drug resistance mutations in untreated, recently infected patients from Burkina Faso, Cote d'Ivoire, Senegal, Thailand, and Vietnam: the ANRS 12134 study AIDS Res. Hum. Retroviruses 25 (11), 1193-1196 (20 2e-171 299
261PR
38RT
299
261PR
38RT
100 HIVDB
Ayouba (2013) Evidence for continuing cross-species transmission of SIVsmm to humans: characterization of a new HIV-2 lineage in rural Cote d'Ivoire AIDS 27 (15), 2488-2491 (2013) 0  
2
1RT
2IN
0 Pending
Azam (2012) Genotypic alterations in the protease gene of HIV-1 clinical isolates from ART naive and treated subjects at a tertiary care hospital of northern India Unpublished 1e-60  
51
51PR
0 need annotation
Azam (2013) Prevalence of primary drug resistance-associated mutations to protease inhibitors in HIV-1 infected patients Unpublished 4e-61  
50
50PR
0 ARV Rx and/or other data are N/A
Azevedo-Pereira (1998) Primary human immunodeficiency virus type 2 (HIV-2) isolates infect CD4-negative cells via CCR5 and CXCR4: comparison with HIV-1 and simian immunodeficiency virus and relevance to cell tropism in vivo. J Virol. 2e-97  
1
1RT
1IN
0 Laboratory/experimental isolate
Baalwa (2012) Molecular identification, cloning and characterization of transmitted/founder HIV-1 subtype A, D and A/D infectious molecular clones Virology 436 (1), 33-48 (2013) 0  
477
49PR
194RT
477IN
0 Evolution/quasispecies study
Babic (2005) PREVALENCE of antiretroviral drug resistance mutations and HIV-1 non-B subtypes in newly diagnosed drug-naive patients in Slovenia, 2000-2004 Virus Res. 118 (1-2), 156-163 (2006) 0 76
76PR
76RT
76
63PR
76RT
100 HIVDB
Babic (2005) MOLECULAR epidemiology of HIV-1 subtypes based on analysis of pol sequences in Slovenia, 1996-2005 J. Med. Virol. 78 (8), 997-1002 (2006) 0  
6
3PR
6RT
0 Case report(s) / study subset
Bacheler (2000) HUMAN immunodeficiency virus type 1 mutations selected in patients failing efavirenz combination therapy Antimicrob. Agents Chemother. 44 (9), 2475-2484 (2000) 1e-130 3669
3646PR
3662RT
3708
3708PR
3708RT
98 HIVDB
Bacheler (2001) GENOTYPIC correlates of phenotypic resistance to efavirenz in virus isolates from patients failing nonnucleoside reverse transcriptase inhibitor therapy J. Virol. 75 (11), 4999-5008 (2001) 1e-126 67
66PR
67RT
87
84PR
87RT
77 HIVDB
Badreddine (2007) IDENTIFICATION and Characterization of HIV Type 1 Subtypes Present in the Kingdom of Saudi Arabia: High Level of Genetic Diversity Found AIDS Res. Hum. Retroviruses 23 (5), 667-674 (2007) 0 60
6PR
6RT
60IN
60
6RT
60IN
100 HIVDB
Baeten (2011) Herpes simplex virus type 2 suppressive therapy with acyclovir or valacyclovir does not select for specific HIV-1 resistance in HIV-1/HSV-2 dually infected persons J. Infect. Dis. 203 (1), 117-121 (2011) 2e-168  
2
2RT
0 Pending
Baeten (2013) Antiretroviral prophylaxis for HIV prevention in heterosexual men and women N. Engl. J. Med. 367 (5), 399-410 (2012) 0  
139
76PR
67RT
0 Case report(s) / study subset
Baier (1990) COMPLETE nucleotide sequence of a simian immunodeficiency virus from African green monkeys: a novel type of intragroup divergence Virology 176 (1), 216-221 (1990) 1e-109 1
1PR
1RT
1IN
1
1PR
1RT
1IN
100 HIVDB
Bailey (2007) EVOLUTION of HIV-1 in an HLA-B*57-Positive Patient during Virologic Escape J. Infect. Dis. 196 (1), 50-55 (2007) 0  
38
35RT
6IN
0 Evolution/quasispecies study
Bailey (2008) TRANSMISSION of Human Immunodeficiency Virus Type 1 from a Patient Who Developed AIDS to an Elite Suppressor J. Virol. 82 (15), 7395-7410 (2008) 0  
14
7PR
7RT
14IN
0 Case report(s) / study subset
Baker (2007) HIV subtypes distribution and implication for antiretroviral treatment in a Ugandan population. J Int Assoc Physicians AIDS Care (Chic) 0 46
45PR
46RT
46
26PR
46RT
100 HIVDB
Balakrishnan (2005) HIV Type 1 Genotypic Variation in an Antiretroviral Treatment-Naive Population in Southern India AIDS Res. Hum. Retroviruses 21 (4), 301-305 (2005) 1e-139 49
49PR
49RT
49
3PR
49RT
100 HIVDB
Balamane (2012) Panel of Prototypical Recombinant Infectious Molecular Clones Resistant to Nevirapine, Efavirenz, Etravirine, and Rilpivirine Antimicrob. Agents Chemother. (2012) In press 1e-176 10
10RT
10
10RT
100 HIVDB
Baldanti (2010) Early emergence of raltegravir resistance mutations in patients receiving HAART salvage regimens J. Med. Virol. 82 (1), 116-122 (2010) 1e-156 11
11IN
11
11IN
100 HIVDB
Baldrich-Rubio (2001) A complex human immunodeficiency virus type 1 A/G/J recombinant virus isolated from a seronegative patient with AIDS from Benin, West Africa J. Gen. Virol. 82 (PT 5), 1095-1106 (2001) 1e-161 1
1PR
1RT
1IN
1
1PR
1RT
1IN
100 HIVDB
Balode (2010) Low prevalence of transmitted drug resistance among newly diagnosed HIV-1 patients in Latvia J. Med. Virol. 82 (12), 2013-2018 (2010) 2e-171 117
117PR
117RT
124
94PR
75RT
94 HIVDB
Balotta (2000) Prevalence of multiple dideoxynucleoside analogue resistance (MddNR) in a multicenter cohort of HIV-1 infected Italian patients with virologic failure. JAIDS 1e-133 149
132PR
149RT
157
137PR
157RT
94 HIVDB
Balotta (2000) PREVALENCE of transmitted nucleoside analogue-resistant HIV-1 strains and pre-existing mutations in pol reverse transcriptase and protease region: outcome after treatment in recently infected individuals Antivir. Ther. (Lond.) 5 (1), 7-14 (2000) 1e-128 71
33PR
38RT
71
33PR
38RT
100 HIVDB
Balotta (2001) INCREASING prevalence of non-clade B HIV-1 strains in heterosexual men and women, as monitored by analysis of reverse transcriptase and protease sequences J. Acquir. Immune Defic. Syndr. 27 (5), 499-505 (2001) 1e-100 19
19PR
19RT
19
19PR
19RT
100 HIVDB
Bang (2007) PREVALENCE of primary antiretroviral resistance: trends in Korea AIDS Res. Hum. Retroviruses 24 (1), 83-85 (2008) 0 81
81PR
81RT
81
77PR
81RT
100 HIVDB
Banke (2009) Positive selection pressure introduces secondary mutations at Gag cleavage sites in human immunodeficiency virus type 1 harboring major protease resistance mutations J. Virol. 83 (17), 8916-8924 (2009) 4e-60  
329
329PR
0 Pending
Bansode (2011) Drug Resistance Mutations in Drug-Naive HIV Type 1 Subtype C-Infected Individuals from Rural Malawi AIDS Res. Hum. Retroviruses 27 (4), 439-444 (2011) 3e-58  
84
84PR
0 ARV Rx and/or other data are N/A
Bao (2008) MOLECULAR tracing of sexual HIV Type 1 transmission in the southwest border of China AIDS Res. Hum. Retroviruses 24 (5), 733-742 (2008) 0 2
2PR
2RT
2
1PR
2RT
100 HIVDB
Bar (2010) Wide variation in the multiplicity of HIV-1 infection among injection drug users J. Virol. 84 (12), 6241-6247 (2010) 3e-16  
390
390IN
0 Evolution/quasispecies study
Bar-Magen (2009) Comparative Biochemical Analysis of HIV-1 Subtype B and C Integrase Enzymes AIDS. 2010 Sep 10;24(14):2171-9. 1e-165  
2
2IN
0 Laboratory/experimental isolate
Barber (2012) Frequency and patterns of protease gene resistance mutations in HIV-infected patients treated with lopinavir/ritonavir as their first protease inhibitor J. Antimicrob. Chemother. (2012) In press 0 28
28PR
28RT
28
9PR
28RT
100 HIVDB
Barditch-Crovo (2001) PHASE i/ii trial of the pharmacokinetics, safety, and antiretroviral activity of tenofovir disoproxil fumarate in human immunodeficiency virus-infected adults Antimicrob. Agents Chemother. 45 (10), 2733-2739 (2001) 4e-96 14
14RT
14
14RT
100 HIVDB
Barlow (2001) RECOMBINANT strains of HIV type 1 in the United Kingdom AIDS Res. Hum. Retroviruses 17 (5), 467-474 (2001) 1e-109  
12
12PR
9RT
0 ARV Rx and/or other data are N/A
Barlow (2003) CHARACTERIZATION of a novel simian immunodeficiency virus (SIVmonNG1) genome sequence from a mona monkey (Cercopithecus mona) J. Virol. 77 (12), 6879-6888 (2003) 3e-92 2
1PR
1RT
2IN
2
1RT
2IN
100 HIVDB
Barnett (1993) DISTINGUISHING features of an infectious molecular clone of the highly divergent and noncytopathic human immunodeficiency virus type 2 UC1 strain J. Virol. 67 (2), 1006-1014 (1993) 0  
1
1PR
1RT
1IN
0 Laboratory/experimental isolate
Barnett (1996) DIRECT Submission Submitted (11-OCT-1995) Barton Bryant, HIV Database, Los Ala 2e-98  
1
1RT
1IN
0 Laboratory/experimental isolate
Barreto (2006) Trends in antiretroviral drug resistance and clade distributions among HIV-1--infected blood donors in Sao Paulo, Brazil. JAIDS 1e-142 6
6PR
6RT
6
4PR
3RT
100 HIVDB
Barrie (1996) NATURAL variation in HIV-1 protease, Gag p7 and p6, and protease cleavage sites within gag/pol polyproteins: amino acid substitutions in the absence of protease inhibitors in mothers and children infected by human immunodeficiency virus type 1 Virology 219 (2), 407-416 (1996) 1e-126  
37
37PR
0 Case report(s) / study subset
Bartolo (2007) HIV-1 genetic diversity and transmitted drug resistance in health care settings in Maputo, Mozambique. JAIDS 0 112
36PR
76RT
112
36PR
76RT
100 HIVDB
Bartolo (2007) Antiretroviral drug resistance surveillance among treatment-naive human immunodeficiency virus type 1-infected individuals in Angola: evidence for low level of transmitted drug resistance. AAC 1e-170 140
19PR
121RT
140
19PR
121RT
100 HIVDB
Bartolo (2008) HIV-1 genetic diversity and transmitted drug resistance in health care settings in Maputo, Mozambique. JAIDS 1e-165 1
1PR
1RT
1
1RT
100 HIVDB
Bartolo (2010) Origin and epidemiological history of HIV-1 CRF14_BG. PLoS One 0 3
3PR
3RT
3IN
3
3RT
3IN
100 HIVDB
Bartolo (2008) Analysis of HIV-1 protease and retrotranscriptase in drug-naive patients from Mozambique Unpublished 1e-59 69
69PR
69
69PR
100 HIVDB
Bartolo (2009) Highly divergent subtypes and new recombinant forms prevail in the HIV/AIDS epidemic in Angola: new insights into the origins of the AIDS pandemic Infect. Genet. Evol. 9 (4), 672-682 (2009) 6e-169 104
103PR
1RT
104
103PR
1RT
100 HIVDB
Bartolo (2014) HIV-1 diversity, transmission dynamics and primary drug resistance in Angola Unpublished 0 257
117PR
140RT
258
118PR
140RT
99 HIVDB
Baryshev (2011) Genetic characterisation of HIV-1 strains recombinant form AG circulating in Siberia, Russia Zh Mikrobiol Epidemiol Immunobiol 0 14
14PR
14RT
14IN
17
1PR
17RT
17IN
82 HIVDB
Baxter (2006) GENOTYPIC changes in human immunodeficiency virus type 1 protease associated with reduced susceptibility and virologic response to the protease inhibitor tipranavir J. Virol. 80 (21), 10794-10801 (2006) 0 1733
1733PR
1394RT
1736
596PR
1397RT
99 HIVDB
Beck (2007) OPTIMIZATION of the Oligonucleotide Ligation Assay (OLA), a Rapid and Inexpensive Test for Detection of HIV-1 Drug-Resistance Mutations, for Non-B Subtypes Unpublished 1e-59  
35
35PR
0 Case report(s) / study subset
Becker (1995) MOLECULAR and phylogenetic characterisation of a Guinea-Bissau-derived human immunodeficiency virus type 2 isolate Unpublished 1e-100  
1
1RT
1IN
0 Case report(s) / study subset
Becker-Pergola (2000) ANALYSIS of HIV type 1 protease and reverse transcriptase in antiretroviral drug-naive Ugandan adults AIDS Res. Hum. Retroviruses 16 (8), 807-813 (2000) 1e-115 54
27PR
27RT
54
27PR
27RT
100 HIVDB
Beer (1999) SIMIAN immunodeficiency virus (SIV) from sun-tailed monkeys (Cercopithecus solatus): evidence for host-dependent evolution of SIV within the C. lhoesti superspecies J. Virol. 73 (9), 7734-7744 (1999) 4e-97 1
1PR
1RT
1IN
1
1RT
1IN
100 HIVDB
Beer (2000) PATTERNS of genomic sequence diversity among their simian immunodeficiency viruses suggest that L'Hoest monkeys (Cercopithecus lhoesti) are a natural lentivirus reservoir J. Virol. 74 (8), 3892-3898 (2000) 3e-99 3
3PR
3RT
3IN
3
2PR
3RT
3IN
100 HIVDB
Beer (2001) CHARACTERIZATION of novel simian immunodeficiency viruses from red-capped mangabeys from Nigeria (SIVrcmNG409 and -NG411) J. Virol. 75 (24), 12014-12027 (2001) 1e-133 2
2PR
2RT
2IN
2
2PR
2RT
2IN
100 HIVDB
Beerenwinkel (2002) DIVERSITY and complexity of HIV-1 drug resistance: a bioinformatics approach to predicting phenotype from genotype Proc. Natl. Acad. Sci. U.S.A. 99 (12), 8271-8276 (2002) 1e-126  
489
466PR
467RT
0 Sequence Quality
Belec (2014) Comparison of the Trugene HIV-1 genotyping assay and the ViroSeq HIV-1 genotyping system v2.0 to detect antiretroviral drug resistance mutations using Cameroonian samples from patients in therapeutic failure according to the World Health Organization criteria Unpublished 0  
38
1PR
37RT
0 Unpublished
Belec (2013) HIV drug resistance mutations in HIV1 variants from adults living in Gabon Unpublished 1e-62  
18
18PR
0 Unpublished
Bellocchi (2009) Subtype Analysis and Mutations to Antiviral Drugs in HIV-1-Infected Patients From Mozambique Before Initiation of Antiretroviral Therapy: Results From the DREAM Programme J Med Virol (2005) 1e-177 59
59PR
59RT
59
59RT
100 HIVDB
Benn (1993) Genomic heterogeneity of AIDS retroviral isolates from North America and Zaire Science 1e-166  
1
1PR
1RT
1IN
0 Case report(s) / study subset
BENVENISTE (1988) Inoculation of baboons and macaques with simian immunodeficiency virus/Mne, a primate lentivirus closely related to human immunodeficiency virus type 2. Unpublished (1990) 6e-99  
1
1PR
1RT
1IN
0 Laboratory/experimental isolate
Bermudez-Aza (2011) Antiretroviral resistance in MSM in Brazil Unpublished 2e-171  
150
107PR
94RT
0 Pending
Bernardin (2003) PRIMARY Infection of a Male Plasma Donor with Divergent HIV Variants from the Same Source Followed by Rapid Fluctuations in Their Relative Frequency and Viral Recombination AIDS Res. Hum. Retroviruses 19 (11), 1009-1015 (2003) 0  
3
3PR
3RT
3IN
0 Case report(s) / study subset
Bernardin (2004) HUMAN immunodeficiency virus mutations during the first month of infection are preferentially found in known cytotoxic T-lymphocyte epitopes J. Virol. 79 (17), 11523-11528 (2005) 0 18
18PR
18RT
18IN
18
18PR
18RT
18IN
100 HIVDB
Bernardin (2006) DIRECT Submission Submitted (12-DEC-2005) Molecular Virology, Blood Systems Re 0  
13
13PR
13RT
13IN
0 Case report(s) / study subset
Bessong (2004) CHARACTERIZATION of Human Immunodeficiency Virus Type 1 from a Previously Unexplored Region of South Africa with a High HIV Prevalence AIDS Res. Hum. Retroviruses 21 (1), 103-109 (2005) 1e-168 26
13PR
13RT
26
13PR
13RT
100 HIVDB
Bessong (2005) RESISTANCE mutational analysis of HIV type 1 subtype C among rural South African drug-naive patients prior to large-scale availability of antiretrovirals AIDS Res. Hum. Retroviruses 22 (12), 1306-1312 (2006) 1e-177 74
39PR
35RT
74
39PR
35RT
100 HIVDB
Bessong (2010) Analysis of pol integrase gene sequences of HIV-1 infected treatment naive individuals in the Limpopo province of South Africa Unpublished 1e-164 88
88IN
89
89IN
98 HIVDB
Betancor (2012) Clinical, virological and biochemical evidence supporting the association of HIV-1 reverse transcriptase polymorphism R284K and thymidine analogue resistance mutations M41L, L210W and T215Y in patients failing tenofovir/emtricitabine therapy Retrovirology 9 (1), 68 (2012) 0  
216
128PR
216RT
0 Pending
Bhalla (2009) Antiretroviral resistance-associated mutations and genomic diversity in reverse transcriptase and protease gene among drug-naive patients Unpublished 6e-58  
9
9PR
0 Unpublished
Bhattacharya (2007) Founder effects in the assessment of HIV polymorphisms and HLA allele associations Science 315 (5818), 1583-1586 (2007) 2e-59  
2
2PR
0 Pending
Bhusal (2013) HIV type 1 subtypes based on the pol gene and drug resistance mutations among Nepalese patients from central region of Nepal Unpublished 0  
20
6PR
20RT
0 need annotation
Bibollet-Ruche (1996) GENETIC diversity of simian immunodeficiency viruses from West African green monkeys: evidence of multiple genotypes within populations from the same geographical locale J. Virol. 71 (1), 307-313 (1997) 1e-30  
10
10IN
0 Gene fragment(s)
Bibollet-Ruche (2004) NEW simian immunodeficiency virus infecting De Brazza's monkeys (Cercopithecus neglectus): evidence for a cercopithecus monkey virus clade J. Virol. 78 (14), 7748-7762 (2004) 0 4
4PR
4RT
4IN
11
4PR
6RT
11IN
36 HIVDB
Bibollet-Ruche (2005) COMPLETE genome analysis of one of the earliest SIVcpzPtt strains from Gabon (SIVcpzGAB2) AIDS Res. Hum. Retroviruses 20 (12), 1377-1381 (2004) 0 1
1PR
1RT
1IN
1
1RT
1IN
100 HIVDB
Bibollet-Ruche (2005) GENETIC characterization of accessory genes from human immunodeficiency viruses type 1 group O Unpublished 3e-08  
14
14IN
0 Gene fragment(s)
Bibollet-Ruche (2012) Efficient SIVcpz replication in human lymphoid tissue requires viral matrix protein adaptation J. Clin. Invest. 122 (5), 1644-1652 (2012) 0  
3
3RT
3IN
0 Laboratory/experimental isolate
Biesinger (2007) CHANGES in simian immunodeficiency virus reverse transcriptase alleles that appear during infection of macaques enhance infectivity and replication in CD4(+) T cells Virology 370 (1), 184-193 (2008) 0  
8
8RT
0 Case report(s) / study subset
Bila (2014) Evolution of Primary HIV Drug Resistance in a Subtype C Dominated Epidemic in Mozambique Unpublished 0 245
245PR
235RT
1IN
245
119PR
177RT
1IN
100 HIVDB
Bila (2012) Evolution of primary HIV drug resistance in a subtype C dominated epidemic in Mozambique Unpublished 0  
112
4PR
112RT
0 Pending
Billong (2013) Population-Based Monitoring of Emerging HIV-1 Drug Resistance on Antiretroviral Therapy and Associated Factors in a Sentinel Site in Cameroon: Low Levels of Resistance but Poor Programmatic Performance PLoS ONE 8 (8), E72680 (2013) 0 145
145PR
145RT
145
16PR
143RT
100 HIVDB
Binverted question markelec (2000) HIGH levels of drug-resistant human immunodeficiency virus variants in patients exhibiting increasing CD4+ T cell counts despite virologic failure of protease inhibitor-containing antiretroviral combination therapy J. Infect. Dis. 181 (5), 1808-1812 (2000) 1e-128 100
100PR
100
100PR
100 HIVDB
Blankson (2007) ISOLATION and Characterization of Replication-Competent HIV-1 from a Subset of Elite Suppressors J. Virol. 81 (5), 2508-2518 (2007) 0  
6
4PR
6RT
6IN
0 Case report(s) / study subset
Blankson (2009) HIV-1 Evolution Following Transmission to an HLA-B*5801 Positive Subject J Infect Dis. 2009 Dec 15;200(12):1820-4. 0  
2
2PR
2RT
2IN
0 Case report(s) / study subset
Bleiber (2001) INDIVIDUAL contributions of mutant protease and reverse transcriptase to viral infectivity, replication, and protein maturation of antiretroviral drug-resistant human immunodeficiency virus type 1 J. Virol. 75 (7), 3291-3300 (2001) 1e-112  
21
15PR
15RT
0 Case report(s) / study subset
Blick (2006) THE Probable Source of Both the Primary Multidrug-Resistant (MDR) HIV-1 Strain Found in a Patient with Rapid Progression to AIDS and a Second Recombinant MDR Strain Found in a Chronically HIV-1-Infected Patient J. Infect. Dis. 195 (9), 1250-1259 (2007) 1e-163  
13
1PR
13RT
0 Case report(s) / study subset
Bodelle (2004) IDENTIFICATION and Genomic Sequence of an HIV Type 1 Group N Isolate from Cameroon AIDS Res. Hum. Retroviruses 20 (8), 902-908 (2004) 0 1
1PR
1RT
1IN
1
1RT
1IN
100 HIVDB
Boeri (2003) EVOLUTIONARY characteristics of HIV-1 variants resistant to protease inhibitors in the absence of drug-selective pressure AIDS Res. Hum. Retroviruses (2003) In press 0  
18
18PR
18RT
0 Case report(s) / study subset
Bogh (2001) INVESTIGATING association between baseline HIV-1 genotypic resistance and virological response among protease in-hibitor-naive patients treated with HAART Unpublished 1e-133  
180
112PR
68RT
0 Unpublished
Bolcic (2012) A clustering phenomenon among HCV-1a strains among patients coinfected with HIV from Buenos Aires, Argentina J. Med. Virol. 84 (4), 570-581 (2012) 1e-179  
4
1PR
4RT
0 Case report(s) / study subset
Bolcic (2011) Diversity of HCV 1a form HIV-coinfected patients in Argentina Unpublished 9e-52  
4
4PR
0 Case report(s) / study subset
Bolivar (2009) The Challenge of HIV-1 Genetic Diversity: Discordant CD4+ T-Cell Count and Viral Load in an Untreated Patient Infected With a Subtype F Strain J. Acquir. Immune Defic. Syndr. 52 (5), 659-661 (2 1e-161  
1
1IN
0 Case report(s) / study subset
Bonhoeffer (2008) Evidence for positive epistasis in HIV-1 Science 306 (5701), 1547-1550 (2004) 1e-175 8735
8735PR
8735RT
8735
5681PR
7808RT
100 HIVDB
Bontell (2011) Transmitted drug resistance and phylogenetic analysis of HIV CRF01_AE in Northern Vietnam Infect. Genet. Evol. 12 (2), 448-452 (2012) 2e-58 60
60PR
60RT
60
60PR
100 HIVDB
Bonura (2010) Transmission of drug-resistant HIV type 1 strains in HAART-naive patients: a 5-year retrospective study in Sicily, Italy. ARHR 0 109
109PR
109RT
109
41PR
109RT
100 HIVDB
Bouchard (2004) HIV Type 1 Drug Resistance among Naive Patients from Venezuela AIDS Res. Hum. Retroviruses 23 (3), 482-485 (2007) 1e-140 37
17PR
20RT
37
17PR
20RT
100 HIVDB
Bouchonnet (2012) Quantification of the effects on viral DNA synthesis of reverse transcriptase mutations conferring human immunodeficiency virus type 1 resistance to nucleoside analogues J. Virol. 79 (2), 812-822 (2005) 0  
1
1RT
0 Laboratory/experimental isolate
Bourara (2007) TARGET cell APOBEC3C can induce limited G-to-A mutation in HIV-1 PLoS Pathog. 3 (10), 1477-1485 (2007) 4e-52  
2
2PR
0 Case report(s) / study subset
Bouzeghoub (2005) HIGH Diversity of HIV Type 1 in Algeria AIDS Res. Hum. Retroviruses 22 (4), 367-372 (2006) 1e-149 248
132PR
116RT
248
132PR
116RT
100 HIVDB
Bouzeghoub (2008) FIRST Observation of HIV Type 1 Drug Resistance Mutations in Algeria AIDS Res. Hum. Retroviruses 24 (11), 1467-1473 (2008) 2e-173  
86
55PR
31RT
0 Pending
Brachtel (2002) DEMONSTRATION of de Novo HIV Type 1 Production by Detection of Multiply Spliced and Unspliced HIV Type 1 RNA in Paraffin-Embedded Tonsils AIDS Res. Hum. Retroviruses 18 (11), 785-790 (2002) 1e-62  
43
43PR
0 Case report(s) / study subset
Bradshaw (2007) NOVEL Drug Resistance Pattern Associated with the Mutations K70G and M184V in Human Immunodeficiency Virus Type 1 Reverse Transcriptase Antimicrob. Agents Chemother. 51 (12), 4489-4491 (2007) 0 9
4PR
9RT
9
9RT
100 HIVDB
Brandin (2003) POL Gene Sequence Variation in Swedish HIV-2 Patients Failing Antiretroviral Therapy AIDS Res. Hum. Retroviruses 19 (7), 543-550 (2003) 3e-97 30
30PR
30RT
30
30PR
30RT
100 HIVDB
Brann (2006) FUNCTIONAL Correlation between a Novel Amino Acid Insertion at Codon 19 in the Protease of Human Immunodeficiency Virus Type 1 and Polymorphism in the p1/p6 Gag Cleavage Site in Drug Resistance and Replication Fitness J. Virol. 80 (12), 6136-6145 (2006) 2e-49  
1
1PR
0 Case report(s) / study subset
Brehm (2011) Failure of initial therapy with two nucleosides and efavirenz is not associated with early emergence of mutations in the C-terminus of HIV-1 reverse transcriptase J. Acquir. Immune Defic. Syndr. 56 (4), 344-348 (2 0 105
105RT
106
106RT
99 HIVDB
Brehm (2012) Frequent Emergence of N348I in HIV-1 Subtype C Reverse Transcriptase with Failure of Initial Therapy Reduces Susceptibility to Reverse-Transcriptase Inhibitors Clin. Infect. Dis. (2012) In press 0 138
138RT
138
138RT
100 HIVDB
Brennan (2009) Identification of human immunodeficiency virus type 1 non-B subtypes and antiretroviral drug-resistant strains in United States blood donors. Transfusion 0 65
62PR
62RT
3IN
65
43PR
62RT
3IN
100 HIVDB
Brennan (1997) GENETIC variation in human immunodeficiency virus type 2: identification of a unique variant from human plasma AIDS Res. Hum. Retroviruses 13 (5), 401-404 (1997) 0.27 1
1PR
1RT
1IN
1
1RT
100 HIVDB
Brennan (2007) HIV-1 Strains Identified in Brazilian Blood Donors: Significant Prevalence of B/F1 Recombinants AIDS Res. Hum. Retroviruses 23 (11), 1434-1441 (2007) 1e-167 82
82IN
85
85IN
96 HIVDB
Brennan (2009) The prevalence of diverse HIV-1 strains was stable in Cameroonian blood donors from 1996 to 2004 J. Acquir. Immune Defic. Syndr. 49 (4), 432-439 (2 1e-166 572
572IN
573
573IN
99 HIVDB
Brennan (2011) Expanded evaluation of blood donors in the United States for human immunodeficiency virus type 1 non-B subtypes and antiretroviral drug-resistant strains: 2005 through 2007 Transfusion 50 (12), 2707-2712 (2010) 0 203
203PR
203RT
203
179PR
203RT
100 HIVDB
Brenner (2006) HIV-1 subtype C viruses rapidly develop K65R resistance to tenofovir in cell culture AIDS 20 (9), F9-F13 (2006) 0  
5
3PR
5RT
0 Laboratory/experimental isolate
Brenner (2006) HIGH Rates of Forward Transmission Events after Acute/Early HIV-1 Infection J. Infect. Dis. 195 (7), 951-959 (2007) 0  
29
27PR
12RT
0 Case report(s) / study subset
Brenner (2010) HIV-1 Integrase Genotypic Analysis: Implications in the Study of HIV-1 Drug Resistance and Subtype Diversification Antimicrob. Agents Chemother. (2010) In press 0 8
8IN
8
7RT
8IN
100 HIVDB
Brenner (2010) Transmission networks of drug resistance acquired in primary/early stage HIV infection AIDS 22 (18), 2509-2515 (2008) 4e-57  
2
2PR
0 ARV Rx and/or other data are N/A
Brenner (2011) Subtype diversity associated with the development of HIV-1 resistance to integrase inhibitors J. Med. Virol. 83 (5), 751-759 (2011) 1e-167 149
149IN
149
149IN
100 HIVDB
Brenner (2011) Spread of HIV-1 Drug-Resistant Sub-epidemics Unpublished 0  
1
1RT
0 Unpublished
Brenner (2011) Transmission Clustering Drives the Onward Spread of the HIV Epidemic Among Men Who Have Sex With Men in Quebec J. Infect. Dis. 204 (7), 1115-1119 (2011) 0  
200
176PR
130RT
0 Case report(s) / study subset
Brigido (2005) SHORT Communication: Molecular Characteristics of HIV Type 1 Circulating in Sao Paulo, Brazil AIDS Res. Hum. Retroviruses 21 (7), 673-682 (2005) 0  
192
86PR
106RT
0 Pending
Brigido (2008) HIV type 1 subtype C and CB Pol recombinants prevail at the cities with the highest AIDS prevalence rate in Brazil AIDS Res. Hum. Retroviruses 23 (12), 1579-1586 (2007) 0 210
164PR
101RT
210
126PR
97RT
100 HIVDB
Brigido (2010) Southern Brazil HIV Type 1 C Expansion into the State of Sao Paulo, Brazil AIDS Res. Hum. Retroviruses 27 (3), 339-344 (2011) 0 209
209PR
200RT
325
267PR
75RT
15IN
64 HIVDB
Brindeiro (1999) SEQUENCE diversity of the reverse transcriptase of human immunodeficiency virus type-1 from Brazilian untreated individuals Antimicrob. Agents Chemother. (1999) In press 2e-91 18
18RT
18
18RT
100 HIVDB
Brindeiro (2003) BRAZILIAN Network for HIV Drug Resistance Surveillance (HIV-BResNet): a survey of chronically infected individuals AIDS 17 (7), 1063-1069 (2003) 1e-145 350
199PR
191RT
357
199PR
199RT
98 HIVDB
Briones (2000) DYNAMICS of dominance of a dipeptide insertion in reverse transcriptase of HIV-1 from patients subjected to prolonged therapy Virus Res. 66 (1), 13-26 (2000) 1e-128  
186
180PR
186RT
0 Evolution/quasispecies study
Briones (2003) MEMORY in retroviral quasispecies: experimental evidence and theoretical model for human immunodeficiency virus J. Mol. Biol. 331 (1), 213-229 (2003) 1e-126  
15
15PR
15RT
0 Evolution/quasispecies study
Brockman (2012) Uncommon Pathways of Immune Escape Attenuate HIV-1 integrase Replication Capacity J. Virol. 86 (12), 6913-6923 (2012) 1e-167 88
88IN
88
88IN
100 HIVDB
Brooks (2013) Local phylogenetic analysis identifies distinct trends in transmitted HIV drug resistance: implications for public health interventions BMC Infect. Dis. 13 (1), 509 (2013) 2e-62 219
219PR
219RT
219
219PR
100 HIVDB
Brown (2009) Phylogenetic reconstruction of transmission events from individuals with acute HIV infection: toward more-rigorous epidemiological definitions J. Infect. Dis. 199 (3), 427-431 (2009) 1e-172 164
164PR
164RT
164
137PR
77RT
100 HIVDB
Brown (1999) SEQUENCE clusters in human immunodeficiency virus type 1 reverse transcriptase are associated with subsequent virological response to antiretroviral therapy J. Infect. Dis. 180 (4), 1043-1049 (1999) 1e-130  
55
55PR
55RT
0 DNAChip
Brown (2005) BIOLOGIC and genetic characterization of a panel of 60 human immunodeficiency virus type 1 isolates, representing clades A, B, C, D, CRF01_AE, and CRF02_AG, for the development and assessment of candidate vaccines J. Virol. 79 (10), 6089-6101 (2005) 0 21
21PR
21RT
21IN
21
21PR
21RT
21IN
100 HIVDB
Brumme (2007) EVIDENCE of Differential HLA Class I-Mediated Viral Evolution in Functional and Accessory/Regulatory Genes of HIV-1 PLoS Pathog. 3 (7), E94 (2007) 0 823
823PR
594RT
823
785PR
594RT
100 HIVDB
Brumme (2009) HLA-associated immune escape pathways in HIV-1 subtype B Gag, Pol and Nef proteins PLoS ONE 4 (8), E6687 (2009) 0 1279
683PR
677RT
975IN
1285
415PR
691RT
1129IN
99 HIVDB
Bruselles (2009) Use of massive parallel pyrosequencing for near full-length characterization of a unique HIV BF recombinant associated with a fatal primary infection AIDS Res Hum Retroviruses. 2009 Sep;25(9):937-42. 0  
1
1PR
1RT
1IN
0 Case report(s) / study subset
Buckheit (2012) Long term control of viral replication in a group O, Human immunodeficiency virus type 1 infected individual Unpublished 0  
1
1RT
1IN
0 Case report(s) / study subset
Buckheit (2012) Host Factors Dictate Control of Viral Replication in two HIV-1 Controller/Chronic Progressor Transmission Pairs Nat Commun (2012) In press 0  
4
4PR
4RT
4IN
0 Case report(s) / study subset
Buckheit (2013) Infection with defective virus results in different clinical outcomes of infection in three HIV-1 infected individuals Unpublished 0  
3
1PR
3RT
3IN
0 Case report(s) / study subset
Buckton (2008) DEVELOPMENT and optimization of an internally controlled dried blood spot assay for surveillance of human immunodeficiency virus type-1 drug resistance J. Antimicrob. Chemother. 62 (6), 1191-1198 (2008) 0  
17
17RT
0 Case report(s) / study subset
Bulgheroni (2001) UNUSUAL codon 69 insertions: influence on human immunodeficiency virus type 1 reverse transcriptase drug susceptibility J. Clin. Virol. 29 (1), 27-32 (2004) 4e-77  
3
3RT
0 Case report(s) / study subset
Buonaguro (2006) SCREENING of HIV-1 isolates by reverse heteroduplex mobility assay and identification of non-B subtypes in Italy J. Acquir. Immune Defic. Syndr. 37 (2), 1295-1306 (2004) 0  
3
3RT
3IN
0 Case report(s) / study subset
Burda (2005) HIV-1 CRF09_cpx circulates in the North West Province of Cameroon where CRF02_AG infections predominate and recombinant strains are common AIDS Res. Hum. Retroviruses 20 (12), 1358-1363 (2004) 2e-50  
17
17PR
0 Sequence quality
Burda (2009) HIV-1 reverse transcriptase drug-resistance mutations in chronically infected individuals receiving or naive to HAART in Cameroon J. Med. Virol. 82 (2), 187-196 (2010) 0 29
29RT
29
29RT
100 HIVDB
Bure (2011) Genetic analysis of pol gene of HIV-1 in Indian children Unpublished 2e-60  
13
13PR
0 Unpublished
Burkala (2005) COMPARTMENTALIZATION of HIV-1 in the central nervous system: role of the choroid plexus AIDS 19 (7), 675-684 (2005) 1e-152  
140
123PR
140RT
0 Evolution/quasispecies study
Burns (2005) SEQUENCE variability of the integrase protein from a diverse collection of HIV type 1 isolates representing several subtypes AIDS Res. Hum. Retroviruses 18 (14), 1031-1041 (2002) 1e-159 21
21IN
21
21IN
100 HIVDB
Bussmann (2005) HIV-1 subtype C drug-resistance background among ARV-naive adults in Botswana. Antivir Chem Chemother 0 71
71PR
71RT
71
64PR
71RT
100 HIVDB
Buzon (2008) Raltegravir susceptibility and fitness progression of HIV type-1 integrase in patients on long-term antiretroviral therapy. Antivir Ther 1e-167 123
123IN
135
135IN
91 HIVDB
Buzon (2011) Combined antiretroviral therapy and immune pressure lead to in vivo HIV-1 recombination with ancestral viral genomes J. Acquir. Immune Defic. Syndr. (2011) In press 5e-59  
21
21PR
0 Evolution/quasispecies study
Bychenko (2009) Isolation and characterization of new HIV-1 subtype A1 strain from Russia, envelope proteins variability analysis Unpublished 0  
1
1PR
1RT
1IN
0 Case report(s) / study subset
Byrn (2006) HIV-1 in semen: an isolated virus reservoir Lancet 350 (9085), 1141 (1997) 5e-58  
37
37PR
0 Case report(s) / study subset
Cabana (1999) EMERGENCE and genetic evolution of HIV-1 variants with mutations conferring resistance to multiple reverse transcriptase and protease inhibitors J. Med. Virol. 59 (4), 480-490 (1999) 1e-125 92
54PR
38RT
92
54PR
38RT
100 HIVDB
Caetano (2013) Epidemiological and molecular profile of HIV infection among female sex workers in central Brazil Unpublished 9e-61  
4
4PR
0 Unpublished
Calazans (2003) LOW Accumulation of L90M in Protease from Subtype F HIV-1 with Resistance to Protease Inhibitors Is Caused by the L89M Polymorphism J. Infect. Dis. 191 (11), 1961-1970 (2005) 1e-126 51
51PR
51RT
52
52PR
51RT
98 HIVDB
Cali (2004) EVIDENCE for host-driven selection of the HIV type 1 vpr gene in vivo during HIV disease progression in a transfusion-acquired cohort AIDS Res. Hum. Retroviruses 21 (8), 728-733 (2005) 0  
15
15PR
15RT
15IN
0 Case report(s) / study subset
Calugi (2006) ENTIRE Genome of a Strain of Human Immunodeficiency Virus Type 1 with a Deletion of nef That Was Recovered 20 Years after Primary Infection: Large Pool of Proviruses with Deletions of env J. Virol. 80 (23), 11892-11896 (2006) 0  
1
1RT
1IN
0 Sequence quality
Calvez (2002) IMPACT of stavudine phenotype and thymidine analogues mutations on viral response to stavudine plus lamivudine in ALTIS 2 ANRS trial Antivir. Ther. (Lond.) 7 (3), 211-218 (2002) 2e-94  
26
26RT
0 ARV Rx and/or other data are N/A
Candotti (1999) AIDS in an HIV-seronegative Ghanaian woman with intersubtype A/G recombinant HIV-1 infection J. Med. Virol. 62 (1), 1-8 (2000) 1e-165  
1
1PR
1RT
1IN
0 Case report(s) / study subset
Canducci (2008) Dynamic patterns of human immunodeficiency virus type 1 integrase gene evolution in patients failing raltegravir-based salvage therapies. AIDS 1e-154 37
37IN
37
37IN
100 HIVDB
Canducci (2011) Cross-resistance profile of the novel integrase inhibitor Dolutegravir (S/GSK1349572) using clonal viral variants selected in patients failing raltegravir J. Infect. Dis. 204 (11), 1811-1815 (2011) 1e-167 38
38IN
38
38IN
100 HIVDB
Capel (2012) Evolution of the human immunodeficiency virus type 1 protease: effects on viral replication capacity and protease robustness J. Gen. Virol. 93 (PT 12), 2625-2634 (2012) 1e-59  
6
6PR
0 ARV Rx and/or other data are N/A
Capel (2013) Significant changes in integrase-associated HIV-1 replication capacity between early and late isolates Virology 444 (1-2), 274-281 (2013) 0 94
94IN
94
94IN
100 HIVDB
Caplinskas (2012) Distinct HIV-1 strains in different risk groups and the absence of new infections by drug-resistant strains in Lithuania AIDS Res. Hum. Retroviruses (2012) In press 0  
27
9PR
27RT
0 ARV Rx and/or other data are N/A
Caragounis (2008) Comparison of HIV-1 pol and env sequences of blood, CSF, brain and spleen isolates collected ante-mortem and post-mortem Acta Neurol. Scand. 117 (2), 108-116 (2008) 1e-58  
21
21PR
0 Evolution/quasispecies study
Cardoso (2009) HIV-1 pol phylogenetic diversity and antiretroviral resistance mutations in treatment naive patients from Central West Brazil J. Clin. Virol. 46 (2), 134-139 (2009) 2e-171 94
94PR
94RT
94
89PR
19RT
100 HIVDB
Cardoso (2009) High level of multidrug resistance mutations in HIV type 1 pol gene and resistance-associated mutations to enfuvirtide (T-20) among antiretroviral-experienced patients from central Brazil AIDS Res. Hum. Retroviruses 25 (10), 943-950 (2009 1e-169 30
30PR
30RT
30
27PR
4RT
100 HIVDB
Cardoso (2010) HIV-1 primary and secondary antiretroviral drug resistance and genetic diversity among pregnant women from central Brazil J. Med. Virol. 82 (3), 351-357 (2010) 9e-170  
75
73PR
7RT
0 Pending
Cardoso (2011) Molecular Characteristics of HIV Type 1 Infection Among Prisoners from Central Western Brazil AIDS Res. Hum. Retroviruses (2011) In press 2e-171  
25
24PR
4RT
0 Pending
Caride (2000) DRUG-RESISTANT reverse transcriptase genotyping and phenotyping of B and non-B subtypes (F and A) of human immunodeficiency virus type I found in Brazilian patients failing HAART Virology 275 (1), 107-115 (2000) 5e-89  
14
14RT
0 ARV Rx and/or other data are N/A
Caride (2001) GENOTYPIC and phenotypic evidence of different drug-resistance mutation patterns between B and non-B subtype isolates of human immunodeficiency virus type 1 found in Brazilian patients failing HAART Virus Genes 23 (2), 193-202 (2001) 1e-123 14
14PR
28
28PR
50 HIVDB
Carneiro-Proietti (1997) DIRECT Submission Submitted (14-NOV-1996) Lab. Virus, Dept. Microbiologia, Uni 1e-128  
1
1PR
0 Case report(s) / study subset
Caron (2008) HUMAN immunodeficiency virus type 1 seroprevalence and antiretroviral drug resistance-associated mutations in miners in Gabon, central Africa AIDS Res. Hum. Retroviruses 24 (9), 1225-1228 (2008) 5e-60 18
18PR
18
18PR
100 HIVDB
Caron (2011) Increasing HIV-1 Polymorphism Diversity and Resistance to Antiretroviral Drugs in Untreated Pregnant Women from Gabon, central Africa Unpublished 0 101
99PR
94RT
101
64PR
87RT
100 HIVDB
Carr (1996) Full-length sequence and mosaic structure of a human immunodeficiency virus type 1 isolate from Thailand J. Virol. 70 (9), 5935-5943 (1996) 0 1
1PR
1RT
1IN
1
1RT
1IN
100 HIVDB
Carr (1998) FULL genome sequences of human immunodeficiency virus type 1 subtypes G and A/G intersubtype recombinants Virology 247 (1), 22-31 (1998) 1e-164 3
3PR
3RT
3IN
3
3PR
3RT
3IN
100 HIVDB
Carr (1999) CHARACTERIZATION of subtype A HIV-1 from Africa by full genome sequencing AIDS 13 (14), 1819-1826 (1999) 1e-166 7
7PR
7RT
7IN
7
7PR
7RT
7IN
100 HIVDB
Carr (1999) DIRECT Submission Submitted (07-JUL-1998) Molecular Epidemiology, Henry M. Jac 1e-164 4
4PR
4RT
4IN
4
4PR
4RT
4IN
100 HIVDB
Carr (2001) THE AG Recombinant IbNG and Novel Strains of Group M HIV-1 are Common in Cameroon Virology (2001) In press 1e-166 7
7PR
7RT
7IN
7
7PR
7RT
7IN
100 HIVDB
Carr (2001) DIVERSE BF recombinants have spread widely since the introduction of HIV-1 into South America AIDS 15 (15), F41-F47 (2001) 1e-165 21
21PR
21RT
21IN
21
21PR
21RT
21IN
100 HIVDB
Carr (2004) OUTBREAK of a West African recombinant of HIV-1 in Tashkent, Uzbekistan J. Acquir. Immune Defic. Syndr. 39 (5), 570-575 (2005) 0 245
233PR
232RT
12IN
246
242PR
241RT
12IN
99 HIVDB
Carr (2005) HIV Subtype and Drug Resistance Patterns among Drug Naive Persons in Jos, Nigeria Unpublished 0 23
23PR
23RT
7IN
23
9PR
23RT
7IN
100 HIVDB
Carr (2006) HIGH Genetic Complexity of HIV-1 in low-prevalence, rural regions of Cameroon Unpublished 0 2
2PR
2RT
2IN
2
1PR
2RT
2IN
100 HIVDB
Carr (2008) IDENTIFICATION of CRF17_BF in Four South American Countries Unpublished 0  
6
1PR
6RT
6IN
0 Case report(s) / study subset
Carr (2010) HIV-1 Recombinants with Multiple Parental Strains in Low-Prevalence, Remote Regions of Cameroon Retrovirology. 2010 Apr 28;7:39. 0 24
24PR
23RT
24IN
24
24RT
24IN
100 HIVDB
Carrera (2010) Identification of unusual and novel HIV type 1 spliced transcripts generated in vivo AIDS Res. Hum. Retroviruses 26 (7), 815-820 (2010) 0.002  
1
1IN
0 Gene fragment(s)
Carrion (2002) CIRCULATING Recombinant Form CRF02_AG in South America AIDS Res. Hum. Retroviruses 19 (4), 329-332 (2003) 1e-163 2
2PR
2RT
2IN
2
2PR
2RT
2IN
100 HIVDB
Carrion (2004) DOCUMENTATION of subtype C HIV Type 1 strains in Argentina, Paraguay, and Uruguay AIDS Res. Hum. Retroviruses 20 (9), 1022-1025 (2004) 0 2
2PR
2RT
2IN
7
7PR
7RT
2IN
28 HIVDB
Carrion (2009) Molecular characterization of the human immunodeficiency virus type 1 among children in Lima, Peru AIDS Res. Hum. Retroviruses (2009) In press 1e-173  
2
2RT
0 Pending
Carvalho (2010) Moderate prevalence of transmitted drug resistance and interiorization of HIV type 1 subtype C in the inland north state of Tocantins, Brazil. ARHR 1e-144 30
30PR
30RT
31
31PR
1RT
96 HIVDB
Carvalho (2010) Secondary Drug Resistance And HIV-1 Phylogenetic Diversity In North Brazil, Tocantins State Unpublished 4e-51  
5
5PR
0 Unpublished
Carvalho (2011) Moderate Prevalence of Transmitted Drug Resistance and Interiorization of HIV Type 1 Subtype C in the Inland North State of Tocantins, Brazil AIDS Res. Hum. Retroviruses 27 (10), 1081-1087 (20 1e-170 16
16PR
16RT
18
18PR
2RT
88 HIVDB
Casado (2003) NEAR Full-Length Genome Characterization of an HIV Type 1 CRF05_DF Virus from Spain AIDS Res. Hum. Retroviruses 19 (8), 719-725 (2003) 0 1
1PR
1RT
1IN
1
1PR
1RT
1IN
100 HIVDB
Casado (2005) DIRECT Submission Submitted (18-JAN-2005) Patogenia Viral, Instituto de Salud 1e-126  
1
1PR
1RT
1IN
0 Case report(s) / study subset
Casado (2007) IDENTIFICATION of a novel HIV-1 circulating ADG intersubtype recombinant form (CRF19_cpx) in Cuba J. Acquir. Immune Defic. Syndr. 40 (5), 532-537 (2005) 0 2
2PR
2RT
2IN
2
1PR
2RT
2IN
100 HIVDB
Castelbranco (2010) Frequency of Primary Resistance to Antiretroviral Drugs and Genetic Variability of HIV-1 Among Infected Pregnant Women Recently Diagnosed in Luanda-Angola AIDS Res. Hum. Retroviruses 26 (12), 1313-1316 (20 3e-57 5
5PR
5RT
5
5PR
100 HIVDB
Castillo (2009) Surveillance of HIV Type 1 Drug Resistance among Naive Patients from Venezuela AIDS Res. Hum. Retroviruses (2009) In press 4e-173 111
65PR
46RT
111
65PR
46RT
100 HIVDB
Castro (2002) MOLECULAR epidemiology of HIV-1 in Venezuela: high prevalence of HIV-1 subtype B and identification of a B/F recombinant infection J. Acquir. Immune Defic. Syndr. 32 (3), 338-344 (2003) 7e-77  
2
1PR
1RT
0 Case report(s) / study subset
Castro (2004) BODY Compartments Follow-up & HIV-1 Mosaic Genome Definition. E7109254 (in) EXTENDED ABSTRACT BOOK, XV INTERNATIONAL AIDS CONFERENC 1e-135  
4
4RT
0 Case report(s) / study subset
Castro (2004) RESISTANCE mutations and molecular characterization of HIV-1 isolates from Venezuelan patients with virological failure Unpublished 1e-136  
41
20PR
21RT
0 Pending
Castro (2009) HIV-1 transmission network of 103N resistance mutation in Southwest Switzerland AIDS Res Hum Retroviruses. 2010 Sep 23. [Epub ahead of print 0 19
19PR
19RT
19
14PR
10RT
100 HIVDB
Castro (2010) HIV-1 Drug Resistance Transmission Networks in Southwest Switzerland AIDS Res. Hum. Retroviruses 26 (11), 1233-1238 (20 4e-170 6
6PR
6RT
6
4PR
5RT
100 HIVDB
Caumont (2001) Sequence analysis of env C2/V3, gag p17/p24, and pol protease regions of 25 HIV type 1 isolates from Ho Chi Minh city, Vietnam. ARHR 9e-98 26
24PR
2RT
27
25PR
2RT
96 HIVDB
Cavaco-Silva (2014) HIV-2 integrase polymorphisms and longitudinal genotypic analysis of HIV-2 infected patients failing a raltegravir-containing regimen Unpublished 2e-128  
73
73IN
0 Pending
Ceccherini-Silberstein (2005) IDENTIFICATION of the minimal conserved structure of HIV-1 protease in the presence and absence of drug pressure AIDS 18 (12), F11-F19 (2004) 0  
477
242PR
477RT
0 Pending
Ceccherini-Silberstein (2006) HIGH sequence conservation of human immunodeficiency virus type 1 reverse transcriptase under drug pressure despite the continuous appearance of mutations J. Virol. 79 (16), 10718-10729 (2005) 0  
178
123PR
178RT
0 Pending
Ceccherini-Silberstein (2007) IMPACT of HIV-1 Reverse Transcriptase Polymorphism F214L on Virological Response to Thymidine Analogue-Based Regimens in Antiretroviral Therapy (ART)-Naive and ART-Experienced Patients J. Infect. Dis. 196 (8), 1180-1190 (2007) 0  
354
334PR
88RT
0 Pending
Ceccherini-Silberstein (2007) CHARACTERIZATION and structural analysis of novel mutations in human immunodeficiency virus type 1 reverse transcriptase involved in the regulation of resistance to nonnucleoside inhibitors J. Virol. 81 (20), 11507-11519 (2007) 0  
75
44PR
75RT
0 ARV Rx and/or other data are N/A
Ceccherini-Silberstein (2010) Secondary Integrase Resistance Mutations Found in HIV-1 Minority Quasispecies in Integrase Therapy-Naive Patients Have Little or No Effect on Susceptibility to Integrase Inhibitors Antimicrob. Agents Chemother. 54 (9), 3938-3948 (2 0  
457
429RT
457IN
0 Evolution/quasispecies study
Cenci (1997) SELECTED nucleotide sequence of the pol gene of the monocytotropic strain HIV type 1 BaL AIDS Res. Hum. Retroviruses 13 (7), 629-632 (1997) 5e-49  
1
1RT
0 Case report(s) / study subset
Cenci (2003) LOW Intra-Host Diversity in HIV-1 Protease Gene in Untreated Primary Infection: a Crucial Role for Purifying Selection Unpublished 1e-126  
67
67PR
0 Pending
Cenci (2004) HIV-1 pol genotype divergence in the plasma and cerebrospinal fluid (CSF) of untreated patients in acute and chronic infection Unpublished 1e-108  
58
44PR
14RT
0 Unpublished
Chaix (2003) Stable prevalence of genotypic drug resistance mutations but increase in non-B virus among patients with primary HIV-1 infection in France. AIDS 1e-116 244
244RT
244
244RT
100 HIVDB
Chakrabarti (1999) SEQUENCE of simian immunodeficiency virus from macaque and its relationship to other human and simian retroviruses Nature 328 (6130), 543-547 (1987) 1e-98  
1
1PR
1RT
1IN
0 Laboratory/experimental isolate
Chakrabarti (2011) HIV-1 recombinants among Maipur IDUs Unpublished 0  
1
1RT
1IN
0 Case report(s) / study subset
Chakraborty (2003) FAILURE to detect human immunodeficiency virus type 1 superinfection in 28 HIV-seroconcordant individuals with high risk of reexposure to the virus AIDS Res. Hum. Retroviruses 20 (9), 1026-1031 (2004) 0  
162
81PR
81RT
0 Evolution/quasispecies study
Chakraborty (2003) CAN HIV-1 superinfection compromise antiretroviral therapy? AIDS 18 (1), 132-134 (2004) 2e-87  
8
8RT
0 Case report(s) / study subset
Chaloin (2004) ANTIVIRAL activity of reverse trancriptase inhibitors with different HIV strains and isolates Unpublished 0  
14
14RT
8IN
0 ARV Rx and/or other data are N/A
Chamberland (2011) Transmission of HIV-1 drug resistance in Benin could jeopardise future treatment options. Sex Transm Infect 0 127
127PR
127RT
127
6PR
127RT
100 HIVDB
Chang (2008) Trends of antiretroviral drug resistance in treatment-naive patients with human immunodeficiency virus type 1 infection in Taiwan. J Antimicrob Chemother 5e-49 3
3PR
3RT
3
3PR
100 HIVDB
Chang (2006) MOLECULAR Epidemiology of HIV Type 1 Subtypes in Taiwan: Outbreak of HIV Type 1 CRF07)BC Infection in Intravenous Drug Users AIDS Res. Hum. Retroviruses 22 (11), 1055-1066 (2006) 1e-145 152
152PR
152RT
152
128PR
146RT
100 HIVDB
Chang (2000) DIFFERENTIAL stability of the mRNA secondary structures in the frameshift site of various HIV type 1 viruses AIDS Res. Hum. Retroviruses 15 (17), 1591-1596 (1999) 1e-163  
5
5PR
5RT
5IN
0 Case report(s) / study subset
Chang (2000) SEQUENCE features downstream of the primer-binding site of HIV type 1 subtype E shared by subtype G and a subset of subtype A AIDS Res. Hum. Retroviruses 15 (18), 1703-1706 (1999) 1e-163  
1
1PR
1RT
1IN
0 Case report(s) / study subset
Chantratita (1999) HIV-1 resistant to antiretroviral drugs in Thailand Unpublished 1e-128  
722
342PR
469RT
0 ARV Rx and/or other data are N/A
Chantratita (2005) Prevalence of mutations related to HIV-1 antiretroviral drug resistance in Thailand, 2003 Unpublished 8e-58  
145
145PR
0 Unpublished
Chaplin (2011) Impact of HIV Type 1 Subtype on Drug Resistance Mutations in Nigerian Patients Failing First-Line Therapy AIDS Res. Hum. Retroviruses 27 (1), 71-80 (2011) 1e-168 2
2PR
2RT
2
2RT
100 HIVDB
Charpentier (2009) Prevalence of HIV-1 drug resistance in HIV-1 infected patients treated in Douala, Cameroon Unpublished 0 56
54PR
56RT
56
1PR
56RT
100 HIVDB
Charpentier (2011) High prevalence of antiretroviral drug resistance among HIV-1-untreated patients in Guinea-Conakry and in Niger. Antivir Ther 7e-173 47
47RT
47
47RT
100 HIVDB
Charpentier (2011) Hot spots of integrase genotypic changes leading to HIV-2 resistance to raltegravir Unpublished 1e-100  
12
12IN
0 Pending
Charpentier (2011) Resistance analyses in highly experienced patients failing raltegravir, etravirine and darunavir/ritonavir regimen Unpublished 1e-166  
12
3PR
9IN
0 Pending
Chaturbhuj (2010) Transmitted HIV drug resistance among HIV-infected voluntary counseling and testing centers (VCTC) clients in Mumbai, India. ARHR 0 34
34PR
34RT
34
34RT
100 HIVDB
Chen (2010) Near full-length genomic characterization of a novel HIV-1 CRF07_ BC/CRF08_ BC recombinant strain from Yunnan, China AIDS Res. Hum. Retroviruses (2010) In press 0  
1
1RT
1IN
0 Case report(s) / study subset
Chen (2012) Low Prevalence of Drug Resistance and Genetic Diversity among Newly HIV-1 Diagnosed Individuals from 2009 to 2010 in Western Yunnan, China Unpublished 1e-174 122
122PR
122RT
122
64PR
93RT
100 HIVDB
Chen (2013) Genetic diversity and drug resistance among newly diagnosed and antiretroviral treatment-naive HIV-infected individuals in western Yunnan: a hot area of viral recombination in China BMC Infect. Dis. 12, 382 (2012) 0 177
177PR
177RT
177
106PR
175RT
100 HIVDB
Chen (2013) HIV-1 genotypes and drug resistance threshold survey in Honghe Prefecture of Yunnan Province in 2011 Unpublished 0 41
41PR
41RT
41
25PR
35RT
100 HIVDB
CHEN (2012) Molecular epidemiology and drug resistance of HIV type 1 in patients within late-stage infection in Guangdong province, China Unpublished 0  
179
81PR
179RT
0 Pending
Chen (1996) GENETIC characterization of new West African simian immunodeficiency virus SIVsm: geographic clustering of household-derived SIV strains with human immunodeficiency virus type 2 subtypes and genetically diverse viruses from a single feral sooty mangabey troop J. Virol. 70 (6), 3617-3627 (1996) 0 1
1PR
1RT
1IN
1
1PR
1RT
1IN
100 HIVDB
Cheng (1992) MOLECULAR characterization of HIV-2 (ROD) protease following PCR cloning from virus infected H9 cells Adv. Exp. Med. Biol. 312, 83-88 (1992) 2e-24  
1
1PR
0 Laboratory/experimental isolate
Chibo (2011) HIV Transmissions During Seroconversion Contribute Significantly to New Infections in Men Who Have Sex with Men in Australia AIDS Res. Hum. Retroviruses 28 (5), 460-464 (2012) 2e-174 208
208PR
208RT
208
203PR
25RT
100 HIVDB
Chikata (2013) Host-specific adaptation of HIV-1 subtype B in the Japanese population Unpublished 0 363
363PR
363RT
363IN
363
130PR
363RT
363IN
100 need annotation
Chin (2009) Comparison of genotypic resistance mutations in treatment-naive HIV type 1-infected patients in Korea and China. ARHR 0 64
64PR
64RT
64
46PR
54RT
100 HIVDB
Chin (2006) INVERSE Relationship between Viral Load and Genotypic Resistance Mutations in Korean Patients with Primary HIV Type 1 Infections AIDS Res. Hum. Retroviruses 22 (11), 1142-1147 (2006) 1e-147 52
52PR
52RT
52
49PR
52RT
100 HIVDB
Chin (2007) EARLY identification of seronegative human immunodeficiency virus type 1 infection with severe presentation J. Clin. Microbiol. 45 (5), 1659-1662 (2007) 1e-143  
3
3PR
3RT
0 Case report(s) / study subset
Chin (2007) FACTORS Associated with Short-term Clinical Parameters after Genotypic Resistance Assay in Korean Patients with HIV-1 Subtype B Virologic Failure J Korean Med Sci. 2009 Dec;24(6):1031-7. Epub 2009 Nov 7. 1e-146  
40
23PR
40RT
0 Pending
Chin (2010) Comparison of genotypic resistance mutations in treatment-naive HIV type 1-infected patients in Korea and China AIDS Res. Hum. Retroviruses 26 (2), 217-221 (2010) 6e-171 10
10PR
10RT
10
7PR
7RT
100 HIVDB
Chin (2010) Direct Submission Submitted (09-APR-2010) Aaron Diamond AIDS Researc 0  
1
1RT
1IN
0 Unpublished
Cho (2005) DIRECT Submission Submitted (26-APR-2005) Microbiology, University of Ulsan Co 0  
1
1PR
1RT
1IN
0 Case report(s) / study subset
Cho (2005) FULL-LENGTH sequences of long-term slow progressor Unpublished 0  
6
5PR
6RT
6IN
0 Case report(s) / study subset
Cho (2006) VARIATION of vif gene according to progression rate in Korean patients: association with KRG treatment Unpublished 0.02  
105
105IN
0 Gene fragment(s)
Cho (2006) HIV-1 Vif gene Unpublished 0.02  
75
75IN
0 Gene fragment(s)
Cho (2012) Association of high frequency of gross deletions in the pol and 5' LTR/gag genes with Korean red ginseng intake in HIV-1 infected individuals Unpublished 1e-167  
225
225IN
0 ARV Rx and/or other data are N/A
Cho (2012) Direct Submission Submitted (20-DEC-2011) Department of Microbiology 0  
4
1PR
4RT
4IN
0 Unpublished
Cho (2012) Phylogenetic analysis of full-length pol gene from Korean hemophiliacs and plasma donors infected with Korean subclade B of HIV type 1 Unpublished 0  
15
13PR
4RT
0 Unpublished
Cho (2012) Full-length gene in a long-term survivor infected with HIV-1 CRF02_AG Unpublished 0  
1
1RT
1IN
0 Case report(s) / study subset
Cho (2012) Phylogenetic analysis of full-length Korean subclade of HIV-1 subtype B Unpublished 0  
10
10PR
10RT
10IN
0 Pending
Cho (2013) Frequent genetic defects in long-term survivors for more than 26 years in the absence of antiretroviral therapy in Korea: its association with ginseng treatment Unpublished 0  
9
1PR
9RT
9IN
0 need annotation
Cho (2008) HIGH Frequency of Gross Deletions in the 5' LTR and gag Regions in HIV Type 1-Infected Long-Term Survivors Treated with Korean Red Ginseng AIDS Res. Hum. Retroviruses 24 (2), 181-193 (2008) 1e-52  
19
18PR
1IN
0 Case report(s) / study subset
Cho (2001) LONG-TERM intake of Korean red ginseng in HIV-1-infected patients: development of resistance mutation to zidovudine is delayed Int. Immunopharmacol. 1 (7), 1295-1305 (2001) 4e-96 10
10RT
37
37RT
27 HIVDB
Cho (2002) FREQUENCY of mutations conferring resistance to nucleoside reverse transcriptase inhibitors in human immunodeficiency virus type 1-infected patients in Korea J. Clin. Microbiol. 40 (4), 1319-1325 (2002) 1e-118 6
6RT
23
6PR
22RT
26 HIVDB
Cho (2003) MOLECULAR epidemiologic study of a human immunodeficiency virus 1 outbreak in haemophiliacs B infected through clotting factor 9 after 1990 Vox Sang. 92 (2), 113-120 (2007) 0  
192
154PR
167RT
6IN
0 Evolution/quasispecies study
Cho (2005) FULL sequence of HIV type 1 Korean subtype B in an AIDS case with atypical seroconversion: TAAAA at TATA box AIDS Res. Hum. Retroviruses 21 (11), 961-964 (2005) 0  
1
1RT
1IN
0 Case report(s) / study subset
Cho (2006) HIGH frequency of grossly deleted nef genes in HIV-1 infected long-term slow progressors treated with Korean red ginseng Curr. HIV Res. 4 (4), 447-457 (2006) 0.02  
3
3IN
0 Case report(s) / study subset
Cho (2010) Phylogenetic analysis of full-length pol gene from Korean hemophiliacs and plasma donors infected with Korean subclade B of HIV-1 AIDS Res. Hum. Retroviruses (2010) In press 0  
200
141PR
154RT
162IN
0 Evolution/quasispecies study
Cho (2013) First Report on a T69-ins Insertion in CRF06_cpx HIV Type 1 AIDS Res. Hum. Retroviruses 29 (7), 1079-1084 (201 0  
20
2PR
15RT
14IN
0 Case report(s) / study subset
Choi (1997) HIV type 1 isolate Z321, the strain used to make a therapeutic HIV type 1 immunogen, is intersubtype recombinant AIDS Res. Hum. Retroviruses 13 (4), 357-361 (1997) 1e-164  
1
1PR
1RT
1IN
0 Laboratory/experimental isolate
Choi (2010) Drug susceptibility of human immunodeficiency virus type 1-derived pseudoviruses from treatment-experienced patients to protease inhibitors and reverse transcriptase inhibitors, using a modified single-round assay J. Clin. Virol. (2010) In press 1e-174  
5
5PR
3RT
0 Case report(s) / study subset
Chow (2012) Genome Sequences of a Novel HIV-1 CRF53_01B Identified in Malaysia J. Virol. 86 (20), 11398-11399 (2012) 0 3
3PR
3RT
3IN
3
1PR
3RT
3IN
100 HIVDB
Chow (2013) Molecular Diversity of HIV-1 among People Who Inject Drugs in Kuala Lumpur, Malaysia: Massive Expansion of Circulating Recombinant Form (CRF) 33_01B and Emergence of Multiple Unique Recombinant Clusters PLoS ONE 8 (5), E62560 (2013) 0 127
113PR
112RT
127
87PR
63RT
100 HIVDB
Chow (2014) Complete Genome Sequences of a Novel HIV-1 Circulating Recombinant Form (CRF) 58_01B Identified in Malaysia Unpublished 0  
5
5RT
5IN
0 Unpublished
Church (2009) Analysis of nevirapine (NVP) resistance in Ugandan infants who were HIV infected despite receiving single-dose (SD) NVP versus SD NVP plus daily NVP up to 6 weeks of age to prevent HIV vertical transmission. J Infect Dis 0 49
49PR
49RT
49
15PR
49RT
100 HIVDB
Church (2007) HIV type 1 variants with nevirapine resistance mutations are rarely detected in antiretroviral drug-naive African women with subtypes A, C, and D AIDS Res. Hum. Retroviruses 23 (6), 764-768 (2007) 0 47
47PR
47RT
47
7PR
47RT
100 HIVDB
Ciccozzi (2005) MOLECULAR Diversity of HIV in Albania J. Infect. Dis. 192 (3), 475-479 (2005) 0 66
66PR
66RT
66
63PR
66RT
100 HIVDB
Ciccozzi (2007) THE HIV type 1 epidemic in Bulgaria involves multiple subtypes and is sustained by continuous viral inflow from West and East European countries AIDS Res. Hum. Retroviruses 24 (6), 771-779 (2008) 1e-143 33
33PR
33RT
33
33RT
100 HIVDB
Ciccozzi (2010) Genetic Diversity of HIV-1 in Montenegro AIDS Res. Hum. Retroviruses (2010) In press 0  
32
13PR
32RT
0 Pending
Cilla (2001) MOLECULAR evidence of homosexual transmission of HIV type 2 in Spain AIDS Res. Hum. Retroviruses 17 (5), 417-422 (2001) 7e-05  
4
4RT
0 Case report(s) / study subset
Cinque (2001) EFFECT of genotypic resistance on the virological response to highly active antiretroviral therapy in cerebrospinal fluid AIDS Res. Hum. Retroviruses 17 (5), 377-383 (2001) 1e-129 33
15PR
18RT
57
24PR
33RT
57 HIVDB
Claassen (2009) Direct Submission Submitted (16-NOV-2007) NHLS/University of Stellen 7e-173  
130
130RT
0 Pending
Clarke (2005) REVERSE transcriptase and protease sequences from HIV-1 non-subtype B infected persons in the United Kingdom Unpublished 0 291
135PR
156RT
514
351PR
379RT
56 HIVDB
Clavel (1996) MOLECULAR cloning and polymorphism of the human immune deficiency virus type 2 Nature 324 (6098), 691-695 (1986) 1e-98 1
1PR
1RT
1IN
2
2RT
2IN
50 HIVDB
Cleland (1996) EVOLUTION of zidovudine resistance-associated genotypes in human immunodeficiency virus type 1-infected patients J. Acquir. Immune Defic. Syndr. Hum. Retrovirol. 12 (1), 6-1 1e-123  
370
370RT
0 Gene fragment(s)
Clevenbergh (2002) LONG-TERM virologic outcome in patients infected with multi-nucleoside analogue resistant HIV-1 Antivir. Ther. (Lond.) (2002) In press 1e-121 24
12PR
12RT
24
12PR
12RT
100 HIVDB
Clewley (1998) A novel simian immunodeficiency virus (SIVdrl) pol sequence from the drill monkey, Mandrillus leucophaeus J. Virol. 72 (12), 10305-10309 (1998) 0 2
1PR
1RT
1IN
2
1PR
2RT
1IN
100 HIVDB
Cloyd (1990) SPECTRUM of biological properties of human immunodeficiency virus (HIV-1) isolates Virology 174 (1), 103-116 (1990) 1e-164  
2
2PR
2RT
2IN
0 Case report(s) / study subset
Coleman (2011) Direct Submission Submitted (16-FEB-2011) Infectious Diseases and Pa 0  
1
1RT
0 Laboratory/experimental isolate
Collaco Veras (2011) Molecular Epidemiology of HIV-1 CRF02_AG in Cameroon and African Patients Living in Italy Unpublished 0  
52
3PR
52RT
0 ARV Rx and/or other data are N/A
Collman (2000) An infectious molecular clone of an unusual macrophage-tropic and highly cytopathic strain of human immunodeficiency virus type 1. J Virol 1e-163  
1
1PR
1RT
1IN
0 Laboratory/experimental isolate
Colonno (2004) IDENTIFICATION of I50L as the Signature Atazanavir (ATV)Resistance Mutation in Treatment-Naive HIV-1Infected Patients Receiving ATV-Containing Regimens J. Infect. Dis. 189 (10), 1802-1810 (2004) 1e-59 17
17PR
17
17PR
100 HIVDB
Condra (1996) GENETIC correlates of in vivo viral resistance to indinavir, a human immunodeficiency virus type 1 protease inhibitor J. Virol. 70 (12), 8270-8276 (1996) 1e-130 421
421PR
421
421PR
100 HIVDB
Cong (2006) THE Fitness Cost of Mutations Associated with Human Immunodeficiency Virus Type 1 Drug Resistance Is Modulated by Mutational Interactions J. Virol. 81 (6), 3037-3041 (2007) 1e-172  
4
4RT
0 Laboratory/experimental isolate
Coovadia (2008) PERSISTENT Minority K103N Mutations among Women Exposed to Single-Dose Nevirapine and Virologic Response to Nonnucleoside Reverse-Transcriptase Inhibitor-Based Therapy Clin. Infect. Dis. (2009) In press 1e-168  
99
99RT
0 Pending
Corbet (1999) ENV sequences of simian immunodeficiency viruses from chimpanzees in Cameroon are strongly related to those of human immunodeficiency virus group N from the same geographic area J. Virol. 74 (1), 529-534 (2000) 1e-147 1
1PR
1RT
1IN
2
1PR
1RT
2IN
50 HIVDB
Cornelissen (1997) POL gene diversity of five human immunodeficiency virus type 1 subtypes: evidence for naturally occurring mutations that contribute to drug resistance, limited recombination patterns, and common ancestry for subtypes B and D J. Virol. 71 (9), 6348-6358 (1997) 1e-126 41
41PR
41RT
42
42PR
42RT
97 HIVDB
Cornelissen (2000) SPREAD of distinct human immunodeficiency virus type 1 AG recombinant lineages in Africa J. Gen. Virol. 81 (Pt 2), 515-523 (2000) 2e-86 20
20PR
20RT
21
21PR
21RT
95 HIVDB
Courgnaud (1992) GENETIC differences accounting for evolution and pathogenicity of simian immunodeficiency virus from a sooty mangabey monkey after cross-species transmission to a pig-tailed macaque J. Virol. 66 (1), 414-419 (1992) 4.2 2
2PR
2RT
2IN
2
2RT
100 HIVDB
Courgnaud (2001) CHARACTERIZATION of a novel simian immunodeficiency virus from guereza colobus monkeys (Colobus guereza) in Cameroon: a new lineage in the nonhuman primate lentivirus family J. Virol. 75 (2), 857-866 (2001) 1e-76 3
1PR
1RT
3IN
3
1PR
3RT
3IN
100 HIVDB
Courgnaud (2002) CHARACTERIZATION of a Novel Simian Immunodeficiency Virus with a vpu Gene from Greater Spot-Nosed Monkeys (Cercopithecus nictitans) Provides New Insights into Simian/Human Immunodeficiency Virus Phylogeny J. Virol. 76 (16), 8298-8309 (2002) 4e-97 2
2PR
2RT
2IN
2
2RT
2IN
100 HIVDB
Courgnaud (2003) PARTIAL Molecular Characterization of Two Simian Immunodeficiency Viruses (SIV) from African Colobids: SIVwrc from Western Red Colobus (Piliocolobus badius) and SIVolc from Olive Colobus (Procolobus verus) J. Virol. 77 (1), 744-748 (2003) 1e-149 5
1PR
2RT
5IN
5
5RT
5IN
100 HIVDB
Courgnaud (2003) IDENTIFICATION of a New Simian Immunodeficiency Virus Lineage with a vpu Gene Present among Different Cercopithecus Monkeys (C. mona, C. cephus, and C. nictitans) from Cameroon J. Virol. 77 (23), 12523-12534 (2003) 0 2
2PR
2RT
2IN
2
2RT
2IN
100 HIVDB
Couto-Fernandez (2006) PHYLOGENETIC Analysis of Brazilian HIV Type 1 Subtype D Strains: Tracing the Origin of This Subtype in Brazil AIDS Res. Hum. Retroviruses 22 (2), 207-211 (2006) 0 5
5IN
10
3PR
5RT
5IN
50 HIVDB
Crandall (1999) PARALLEL evolution of drug resistance in HIV: failure of nonsynonymous/synonymous substitution rate ratio to detect selection Mol. Biol. Evol. 16 (3), 372-382 (1999) 1e-121  
41
41PR
0 Evolution/quasispecies study
Crandall (1999) ADVANCES in understanding the evolution of HIV AIDS 13, S39-S47 (1999) 1e-102  
49
49PR
0 Evolution/quasispecies study
Crawford (2014) Occurrence of etravirine/rilpivirine-specific resistance mutations selected by efavirenz and nevirapine in Kenyan patients with non-B HIV-1 subtypes failing antiretroviral therapy AIDS 28, 442-445 (2014) 2e-58  
2
2PR
0 Unpublished
Crowell (2003) OPTIMIZATION of Oligonucleotide Ligation Assay for Detection of Drug Resistance Mutations in Non-Subtype B HIV-1 Unpublished 1e-133  
18
17PR
18RT
0 ARV Rx and/or other data are N/A
Cuevas (2010) Incidence of non-B subtypes of HIV-1 in Galicia, Spain: high frequency and diversity of HIV-1 among men who have sex with men Euro Surveill. 14 (47) (2009) 0 92
92PR
92RT
92
41PR
88RT
100 HIVDB
Cuevas (2009) HIV-1 transmission cluster with T215D revertant mutation among newly diagnosed patients from the Basque Country, Spain J. Acquir. Immune Defic. Syndr. 51 (1), 99-103 (20 6e-59 271
271PR
271RT
271
271PR
100 HIVDB
Cuevas (2010) Biological and genetic characterization of HIV-1 subtype B and non subtype-B transmitted viruses: usefulness for vaccine candidate assessment AIDS Res Hum Retroviruses. 2010 Sep;26(9):1019-25 0  
28
7PR
28RT
28IN
0 Pending
Cunningham (2002) DEVELOPMENT of resistance mutations in women receiving standard antiretroviral therapy who received intrapartum nevirapine to prevent perinatal human immunodeficiency virus type 1 transmission: A substudy of pediatric AIDS clinical trials group protocol 316 J. Infect. Dis. 186 (2), 181-188 (2002) 5e-92  
79
79RT
0 ARV Rx and/or other data are N/A
D'Arrigo (2007) GP41 Sequence Variability in HIV Type 1 Non-B Subtypes Infected Patients Undergoing Enfuvirtide Pressure AIDS Res. Hum. Retroviruses 23 (10), 1296-1302 (2007) 0  
3
3RT
0 Case report(s) / study subset
da Costa (2013) Transmitted HIV Resistance Among Pregnant Young Women Infected with HIV-1 in Brazil AIDS Patient Care STDS 27 (8), 439-441 (2013) 5e-62  
14
14PR
0 Case report(s) / study subset
da Silveira (2011) HIV Type 1 Molecular Epidemiology in pol and gp41 Genes Among Naive Patients from Mato Grosso do Sul State, Central Western Brazil AIDS Res. Hum. Retroviruses 28 (3), 304-307 (2012) 6e-171 41
41PR
41RT
41
41PR
2RT
100 HIVDB
Dahake (2013) Drug Resistance Mutations and Polymorphisms in HIV-1 Subtype C Protease in a Patient Cohort from Mumbai Unpublished 6e-58  
4
4PR
0 Unpublished
Damond (2004) POLYMORPHISM of HIV-2 protease gene and selection of drug resistance mutations in HIV-2 infected patients treated with protease inhibitors J. Clin. Microbiol. (2004) In press 5e-25  
94
94PR
0 Pending
Damond (2006) IDENTIFICATION of a highly divergent HIV type 2 and proposal for a change in HIV type 2 classification AIDS Res. Hum. Retroviruses 20 (6), 666-672 (2004) 0 1
1PR
1RT
1IN
1
1RT
1IN
100 HIVDB
Daniel (1993) SIMIAN immunodeficiency virus from African green monkeys J. Virol. 62 (11), 4123-4128 (1988) 1e-33  
1
1RT
0 Gene fragment(s)
Dash (2007) EXCEPTIONAL molecular and coreceptor-requirement properties of molecular clones isolated from an Human Immunodeficiency Virus Type-1 subtype-C infection Retrovirology 5 (1), 25 (2008) 0  
1
1RT
1IN
0 Case report(s) / study subset
Dau (2010) Connection domain mutations in treatment-experienced patients in the OPTIMA trial J. Acquir. Immune Defic. Syndr. 54 (2), 160-166 (2 0 420
420PR
420RT
420
106PR
415RT
100 HIVDB
Daumer (2010) Short communication: selection of thymidine analogue resistance mutational patterns in children infected from a common HIV type 1 subtype G source AIDS Res. Hum. Retroviruses 26 (3), 275-278 (2010) 1e-166  
3
3RT
0 Evolution/quasispecies study
Davaalkham (2011) Identification of a Current Hot Spot of HIV Type 1 Transmission in Mongolia by Molecular Epidemiological Analysis AIDS Res. Hum. Retroviruses 27 (10), 1073-1080 (20 3e-51  
10
10PR
0 ARV Rx and/or other data are N/A
Dazza (2003) CHARACTERIZATION of a novel vpu-harboring simian immunodeficiency virus from a Dent's Mona monkey (Cercopithecus mona denti) J. Virol. 79 (13), 8560-8571 (2005) 0 1
1PR
1RT
1IN
1
1PR
1RT
1IN
100 HIVDB
De Arellano (2007) IMPACT of Ethnicity and HIV Type 1 Subtype on Response to First-Line Antiretroviral Therapy AIDS Res. Hum. Retroviruses 23 (7), 891-894 (2007) 1e-134  
16
16PR
1RT
0 Pending
de Baar (2001) NATURAL residues versus antiretroviral drug-selected mutations in HIV type 1 group O reverse transcriptase and protease related to virological drug failure in vivo AIDS Res. Hum. Retroviruses 16 (14), 1385-1394 (2000) 2e-17 5
5PR
5RT
5
5PR
5RT
100 HIVDB
de Felipe (2011) Prevalence and resistance mutations of HIV-1 non-B subtypes among immigrants in Southern Spain Unpublished 5e-60  
77
77PR
0 Pending
De Gascun (2012) Human immunodeficiency virus type 1 in ireland: phylogenetic evidence for risk group-specific subepidemics AIDS Res. Hum. Retroviruses 28 (9), 873-881 (2012) 1e-57 16
16PR
16RT
16
16PR
100 HIVDB
de Goede (2013) HIV-1 evolution in patients undergoing immunotherapy with Tat, Rev and Nef expressing dendritic cells followed by treatment interruption Unpublished 0  
34
28PR
34RT
4IN
0 ARV Rx and/or other data are N/A
De Maio (2008) MOLECULAR characterization of the vif accessory gene of HIV-1 from perinatally infected children with different rates of disease progression Unpublished 0.032  
6
6IN
0 Gene fragment(s)
De Maio (2012) APOBEC3 mediated edition in HIV-1 from pediatric patients and its association with APOBEC3G/CUL5 polymorphisms and Vif variability Unpublished 2e-53  
93
93IN
0 Gene fragment(s)
de Medeiros (2011) Co-circulation HIV-1 subtypes B, C, and CRF31_BC in a drug-naive population from Southernmost Brazil: analysis of primary resistance mutations J. Med. Virol. 83 (10), 1682-1688 (2011) 4e-170 71
71PR
71RT
71
69PR
4RT
100 HIVDB
de Mendoza (2005) RESISTANCE to non-nucleoside reverse transcriptase inhibitors and non-B subtypes are on the rise among recent HIV-1 infections in Spain Unpublished 0  
20
19PR
20RT
0 Case report(s) / study subset
de Mendoza (2009) Changes in drug resistance patterns following the introduction of HIV-1 non-B subtypes in Spain AIDS Res Hum Retroviruses. 2009 Oct;25(10):967-72 0  
135
9PR
134RT
0 Pending
de Mulder (2011) Drug resistance prevalence and HIV-1 variant characterization in the naive and pretreated HIV-1-infected paediatric population in Madrid, Spain J. Antimicrob. Chemother. 66 (10), 2362-2371 (2011 0  
207
171PR
79RT
0 Pending
de Mulder (2012) Dynamics of Drug Resistance Prevalence and Susceptibility in the Madrid Cohort of HIV-1 Infected Children: a two decade (1993-2010) analysis Unpublished 1e-58  
7
7PR
0 ARV Rx and/or other data are N/A
de Mulder (2013) High Drug Resistance Prevalence among Vertically HIV-Infected Patients Transferred from Pediatric Care to Adult Units in Spain PLoS ONE 7 (12), E52155 (2012) 3e-59  
4
4PR
0 ARV Rx and/or other data are N/A
de Oliveira (2008) HIGH frequency of BF mosaic genomes among HIV-1-infected children from Sao Paulo, Brazil Arch. Virol. 153 (10), 1799-1806 (2008) 0  
163
90PR
76RT
0 Pending
De Pasquale (2004) DIFFERENCES in HIV-1 pol sequences from female genital tract and blood during antiretroviral therapy Unpublished 0  
39
39PR
39RT
0 ARV Rx and/or other data are N/A
de Ronde (2001) ESTABLISHMENT of new transmissible and drug-sensitive human immunodeficiency virus type 1 wild types due to transmission of nucleoside analogue-resistant virus J. Virol. 75 (2), 595-602 (2001) 2e-91  
8
8RT
0 Case report(s) / study subset
De Sa-Filho (2008) HIV Type 1 pol Gene Diversity and Antiretroviral Drug Resistance Mutations in Santos, Brazil AIDS Res. Hum. Retroviruses (2008) In press 1e-154 83
83PR
83RT
83
31PR
83RT
100 HIVDB
de Silva (2010) HIV-1 subtype distribution in the Gambia and the significant presence of CRF49_cpx, a novel circulating recombinant form Retrovirology 7 (1), 82 (2010) 0 3
3PR
3RT
3IN
3
2RT
3IN
100 HIVDB
Deacon (1995) GENOMIC structure of an attenuated quasi species of HIV-1 from a blood transfusion donor and recipients Science 270 (5238), 988-991 (1995) 1e-161  
1
1PR
1RT
1IN
0 Case report(s) / study subset
Dean (2012) Prevalence of HIV type 1 antiretroviral drug resistance mutations in Vietnam: a multicenter study AIDS Res. Hum. Retroviruses 27 (7), 797-801 (2011) 9e-57 3
3PR
3RT
3
3PR
100 HIVDB
Deeks (1999) NOVEL four-drug salvage treatment regimens after failure of a human immunodeficiency virus type 1 protease inhibitor-containing regimen: antiviral activity and correlation of baseline phenotypic drug susceptibility with virologic outcome J. Infect. Dis. 179 (6), 1375-1381 (1999) 1e-127 15
15PR
15RT
16
16PR
16RT
93 HIVDB
Dehghani (2003) UNIQUE Pattern of Convergent Envelope Evolution in Simian Immunodeficiency Virus-Infected Rapid Progressor Macaques: Association with CD4-Independent Usage of CCR5 J. Virol. 77 (11), 6405-6418 (2003) 1e-101  
2
2RT
2IN
0 Laboratory/experimental isolate
Deho (2008) Subtype assignment and phylogenetic analysis of HIV type 1 strains in patients from Swaziland AIDS Res. Hum. Retroviruses 24 (2), 323-325 (2008) 4e-58 39
39PR
39RT
39
39PR
100 HIVDB
Del Prete (2013) Comparative Characterization of Transfection- and Infection-Derived SIV Challenge Stocks for In Vivo Non-Human Primate Studies J. Virol. (2013) In press 0  
38
38RT
38IN
0 Laboratory/experimental isolate
Delatorre (2012) Evidence of Multiple Introductions and Autochthonous Transmission of the HIV Type 1 CRF02_AG Clade in Brazil AIDS Res. Hum. Retroviruses 28 (10), 1369-1372 (20 2e-168  
1
1RT
0 Case report(s) / study subset
Delatorre (2013) Tracing the Origin and Northward Dissemination Dynamics of HIV-1 Subtype C in Brazil PLoS ONE 8 (9), E74072 (2013) 3e-58  
16
16PR
0 need annotation
Delaugerre (2003) SELECTION of a rare resistance profile in an HIV-1-infected patient exhibiting a failure to an antiretroviral regimen including tenofovir DF J. Clin. Virol. 32 (3), 241-244 (2005) 1e-142 1
1RT
1
1RT
100 HIVDB
Delaugerre (2011) Direct Submission Submitted (11-AUG-2011) Seine Maritime, CHU de Rou 0  
1
1RT
1IN
0 Unpublished
Delgado (2008) High prevalence of unique recombinant forms of HIV-1 in Ghana: molecular epidemiology from an antiretroviral resistance study. JAIDS 0 200
200PR
200RT
200
3PR
199RT
100 HIVDB
Delgado (2001) ANALYSIS of HIV type 1 protease and reverse transcriptase sequences from Venezuela for drug resistance-associated mutations and subtype classification: a UNAIDS study AIDS Res. Hum. Retroviruses 17 (8), 753-758 (2001) 1e-130 199
100PR
100RT
1IN
199
100PR
100RT
100 HIVDB
Delgado (2002) IDENTIFICATION of a newly characterized HIV-1 BG intersubtype circulating recombinant form in Galicia, Spain, which exhibits a pseudotype-like virion structure J. Acquir. Immune Defic. Syndr. 29 (5), 536-543 (2002) 2e-71 9
9PR
9RT
9IN
9
9PR
9RT
100 HIVDB
Delgado (2008) High prevalence of unique recombinant forms of HIV-1 in Ghana: Molecular epidemiology from an antiretroviral resistance study Unpublished 2e-57 2
2PR
2RT
2
2PR
100 HIVDB
Delgado (2010) Identification of a new HIV-1 BF intersubtype circulating recombinant form (CRF44_BF) in Chile AIDS Res Hum Retroviruses. 2010 Jul;26(7):821-6. 0 1
1PR
1RT
1IN
1
1RT
1IN
100 HIVDB
Delgado (2013) Direct Submission Submitted (24-OCT-2012) Biology and Variability of 0  
12
2PR
11RT
11IN
0 need annotation
Delobel (2004) EVIDENCE for compartmentalization of human immunodeficiency virus type 1 in different blood cell types during prolonged suppressive antiretroviral therapy Unpublished 1e-129  
212
212RT
0 Evolution/quasispecies study
Delwart (2011) Genetic Diversity of recently acquired and prevalent HIV, hepatitis B virus, and hepatitis C virus infections in US blood donors. J Infect Dis 0 319
319PR
319RT
321
267PR
320RT
99 HIVDB
Demarest (2009) Virologic failure in first-line human immunodeficiency virus therapy with a CCR5 entry inhibitor, aplaviroc, plus a fixed-dose combination of lamivudine-zidovudine: nucleoside reverse transcriptase inhibitor resistance regardless of envelope tropism Antimicrob. Agents Chemother. 53 (3), 1116-1123 (2 1e-171  
16
10PR
15RT
0 Pending
Demeter (2000) DELAVIRDINE susceptibilities and associated reverse transcriptase mutations in human immunodeficiency virus type 1 isolates from patients in a phase I/II trial of delavirdine monotherapy (ACTG 260) Antimicrob. Agents Chemother. 44 (3), 794-797 (2000) 4e-96 67
67RT
67
67RT
100 HIVDB
Demeter (2001) IMPACT of Clinical Reverse Transcriptase Sequences on the Replication Capacity of HIV-1 Drug-Resistant Mutants Unpublished 4e-96  
15
15RT
0 Laboratory/experimental isolate
Deng (2010) Molecular tracing of HIV type 1 transmission in Hainan province of China AIDS. 2009 May 15;23(8):977-85 0  
1
1RT
0 Pending
Dennis (2012) Phylogenetic insights into HIV transmission in North Carolina AIDS (2012) In press 0 1238
1238PR
1238RT
1373
1037PR
1373RT
90 HIVDB
Derache (2006) GENETIC Diversity and Drug Resistance Mutations in Human Immunodeficiency Virus Type 1 from Untreated Patients in Bamako, Mali Antivir. Ther. (Lond.) (2007) In press 1e-140 98
97PR
96RT
98
22PR
93RT
100 HIVDB
Derache (2008) EVOLUTION of genetic diversity and drug resistance mutations in HIV-1 among untreated patients from Mali between 2005 and 2006 J. Antimicrob. Chemother. 62 (3), 456-463 (2008) 1e-145 162
162PR
156RT
162
59PR
105RT
100 HIVDB
Deris (2011) Direct Submission Submitted (17-NOV-2011) Department of Medical Micr 1e-58  
21
21PR
0 Unpublished
Deris (2012) Genotype testing and antiretroviral resistance patterns in HIV-1 children failing treatment in Kelantan, Malaysia Unpublished 1e-58  
18
18PR
0 Pending
Deris (2012) Direct Submission Submitted (17-NOV-2011) Department of Medical Micr 7e-177  
36
35PR
17RT
0 Pending
Deris (2014) Direct Submission Submitted (17-NOV-2013) Department of Medical Micr 8e-177  
14
14PR
3RT
0 Unpublished
Deroo (2002) HIV-1 subtypes in Luxembourg, 1983-2000 AIDS 16 (18), 2461-2467 (2002) 1e-133  
568
284PR
284RT
0 ARV Rx and/or other data are N/A
Desai (2008) DIRECT Submission Submitted (05-AUG-2008) Department of Neurovirology, Nationa 0  
1
1RT
1IN
0 Case report(s) / study subset
Desai (2009) HIV-2 isolate NNVB-HIV-2 from India, partial genome Unpublished 1e-24  
1
1IN
0 Pending
Desai (2000) MOLECULAR cloning and primary nucleotide sequence analysis of a distinct human immunodeficiency virus isolate reveal significant divergence in its genomic sequences Proc. Natl. Acad. Sci. U.S.A. 83 (21), 8380-8384 (1986) 6e-74  
1
1PR
0 Gene fragment(s)
Descamps (1997) SUSCEPTIBILITY of human immunodeficiency virus type 1 group O isolates to antiretroviral agents: in vitro phenotypic and genotypic analyses J. Virol. 71 (11), 8893-8898 (1997) 3e-19 10
10PR
10RT
10
10PR
10RT
100 HIVDB
Descamps (2011) Direct Submission Submitted (16-DEC-2010) Laboratoire de Virologie, 0 153
153RT
189
189RT
80 HIVDB
Deshpande (2004) MOLECULAR characterization of HIV type 1 isolates from untreated patients of Mumbai (Bombay), India, and detection of rare resistance mutations AIDS Res. Hum. Retroviruses 20 (9), 1032-1035 (2004) 1e-146 248
122PR
126RT
248
122PR
126RT
100 HIVDB
Deshpande (2009) Phylogenetic analysis of HIV-1 reverse transcriptase sequences from 382 patients recruited in JJ Hospital of Mumbai, India, between 2002 and 2008 AIDS Res. Hum. Retroviruses 25 (6), 633-635 (2009) 2e-173 156
156RT
156
156RT
100 HIVDB
Deshpande (2010) Analysis of RT sequences of subtype C HIV-type 1 isolates from indian patients at failure of a first-line treatment according to clinical and/or immunological WHO guidelines AIDS Res. Hum. Retroviruses 26 (3), 343-350 (2010) 9e-171 1
1RT
1
1RT
100 HIVDB
Deshpande (2011) Drug Resistance Mutations in HIV Type 1 Isolates from Naive Patients Eligible for First Line Antiretroviral Therapy in JJ Hospital, Mumbai, India AIDS Res. Hum. Retroviruses 27 (12), 1345-1347 (20 5e-172 52
39PR
13RT
52
39PR
13RT
100 HIVDB
Desire (2001) QUANTIFICATION of human immunodeficiency virus type 1 proviral load by a TaqMan real-time PCR assay J. Clin. Microbiol. 39 (4), 1303-1310 (2001) 3e-15  
16
16IN
0 Gene fragment(s)
Devereux (1999) RAPID decline in detectability of HIV-1 drug resistance mutations after stopping therapy AIDS 13 (18), 123-127 (1999) 1e-128  
48
47PR
43RT
0 Evolution/quasispecies study
Devereux (1999) SUBSTANTIAL correlation between HIV-1 drug-associated resistance mutations detected in plasma and peripheral blood mononuclear cells in heavily treated patients Unpublished 1e-127  
76
38PR
38RT
0 Pending
Devereux (2000) REDUCTION in human immunodeficiency virus type 1 mutations associated with drug resistance after initiating new therapeutic regimens in pretreated patients J. Infect. Dis. 181 (5), 1804-1807 (2000) 1e-127  
80
40PR
40RT
0 Evolution/quasispecies study
Devereux (2000) IN vivo HIV-1 compartmentalisation: drug resistance-associated mutation distribution J. Med. Virol. 66 (1), 8-12 (2002) 1e-122  
213
122PR
91RT
0 Evolution/quasispecies study
Devereux (2001) REPLICATIVE fitness in vivo of HIV-1 variants with multiple drug resistance-associated mutations J. Med. Virol. 65 (2), 218-224 (2001) 1e-124  
27
27PR
27RT
0 Evolution/quasispecies study
Dewhurst (1993) SEQUENCE analysis and acute pathogenicity of molecularly cloned SIVSMM-PBj14 Nature 345 (6276), 636-640 (1990) 1e-101  
5
2RT
5IN
0 Laboratory/experimental isolate
Diallo (2003) THE M184V Substitution in Human Immunodeficiency Virus Type 1 Reverse Transcriptase Delays the Development of Resistance to Amprenavir and Efavirenz in Subtype B and C Clinical Isolates Antimicrob. Agents Chemother. 47 (7), 2376-2379 (2003) 1e-135  
6
3PR
3RT
0 Laboratory/experimental isolate
Diallo (2012) Comparison of HIV-1 resistance profiles in plasma RNA versus PBMC DNA in heavily treated patients in Honduras, a resource-limited country Int J Mol Epidemiol Genet 3 (1), 56-65 (2012) 2e-179  
117
117RT
0 ARV Rx and/or other data are N/A
Diamond (2001) IDENTIFICATION of a simian immunodeficiency virus reverse transcriptase variant with enhanced replicational fidelity in the late stage of viral infection J. Biol. Chem. 276 (26), 23624-23631 (2001) 1.1  
1
1RT
0 Laboratory/experimental isolate
Diamond (2002) MONITORING Fidelity Change of Simian Immunodeficiency Virus Reverse Transcriptase (RT) During the Course of Viral Infection: A New RT Mutation Responsible for In Vivo RT Fidelity Change Unpublished 0.017  
2
2RT
0 Laboratory/experimental isolate
Diaz (2008) SELECTIVE regimes and evolutionary rates of HIV-1 subtype B V3 variants in the Brazilian epidemic Virology 381 (2), 184-193 (2008) 0  
6
4PR
6RT
6IN
0 Case report(s) / study subset
Dietrich (1997) A highly divergent HIV-2-related isolate Nature 342 (6252), 948-950 (1989) 0  
1
1PR
1RT
1IN
0 Case report(s) / study subset
Dieudonne (2005) HIGH prevalence of secondary resistance mutations in Venezuelan HIV-1 isolates Invest. Clin. 47 (1), 27-34 (2006) 1e-145  
30
22PR
30RT
0 Pending
Dilernia (2007) HIV Type 1 Genetic Diversity Surveillance among Newly Diagnosed Individuals from 2003 to 2005 in Buenos Aires, Argentina AIDS Res. Hum. Retroviruses 23 (10), 1201-1207 (2007) 0 283
283PR
283RT
283
222PR
282RT
100 HIVDB
Diop-Ndiaye (2010) Antiretroviral Drug Resistance Mutations in antiretroviral-naive patients from 1998 to 2007 in Senegal AIDS Res Hum Retroviruses. 2010 Sep 19. [Epub ahead of print 0 122
122PR
122RT
122
5PR
122RT
100 HIVDB
Diop-Ndiaye (2010) Antiretroviral drug resistance mutations in antiretroviral-naive patients from Senegal AIDS Res. Hum. Retroviruses 26 (10), 1133-1138 (20 1e-169 2
2PR
2RT
2
2PR
1RT
100 HIVDB
Dos Ramos Farias (2012) HIV, HBV and HCV molecular epidemiology among trans (transvestites, transsexuals and transgender) sex workers in Argentina Unpublished 0  
62
25PR
57RT
0 ARV Rx and/or other data are N/A
Doualla-Bell (2007) HIGH prevalence of the K65R mutation in human immunodeficiency virus type 1 subtype C isolates from infected patients in Botswana treated with didanosine-based regimens Antimicrob. Agents Chemother. 50 (12), 4182-4185 (2006) 1e-176 23
23RT
23
23RT
100 HIVDB
Dourado (2005) HIV in the general population of an urban center in northeast Brazil Unpublished 2e-57  
6
6PR
0 Case report(s) / study subset
Dowling (2002) FORTY-ONE near full-length HIV-1 sequences from Kenya reveal an epidemic of subtype A and A-containing recombinants AIDS 16 (13), 1809-1820 (2002) 1e-166 41
41PR
41RT
41IN
41
41PR
41RT
41IN
100 HIVDB
Drexler (2006) RATES of and Reasons for Failure of Commercial Human Immunodeficiency Virus Type 1 Viral Load Assays in Brazil J. Clin. Microbiol. 45 (6), 2061-2063 (2007) 1e-143  
16
6PR
16RT
0 Case report(s) / study subset
Duan (2001) INHIBITION of purified recombinant reverse transcriptase from wild-type and zidovudine-resistant clinical isolates of human immunodeficiency virus type 1 by zidovudine, stavudine, and lamivudine triphosphates J. Infect. Dis. 184 (10), 1336-1340 (2001) 5e-89  
2
2RT
0 Laboratory/experimental isolate
Dumans (2002) PREVALENCE of protease and reverse transcriptase drug resistance mutations over time in drug-naive human immunodeficiency virus type 1-positive individuals in Rio de Janeiro, Brazil Antimicrob. Agents Chemother. 46 (9), 3075-3079 (2002) 1e-129 101
54PR
47RT
102
55PR
47RT
99 HIVDB
Dumans (2004) SYNONYMOUS Genetic Polymorphisms within Brazilian Human Immunodeficiency Virus Type 1 Subtypes May Influence Mutational Routes to Drug Resistance J. Infect. Dis. 189 (7), 1232-1238 (2004) 0 184
82PR
129RT
188
84PR
131RT
1IN
97 HIVDB
Dumans (2008) DISTINCT resistance mutation and polymorphism acquisition in HIV-1 protease of subtypes B and F1 from children and adult patients under virological failure Infect. Genet. Evol. 9 (1), 62-70 (2009) 0 137
137PR
94RT
137
85PR
67RT
100 HIVDB
Dunne (2001) COMPARISON of genotyping and phenotyping methods for determining susceptibility of HIV-1 to antiretroviral drugs AIDS 15 (12), 1471-1475 (2001) 1e-124 17
17PR
17RT
17
17PR
17RT
100 HIVDB
Duque (1999) Human immunodeficiency virus type 1 recombinant B/G subtypes circulating in Coimbra, Portugal. Clin Microbiol Infect 1e-126 29
29PR
31
31PR
93 HIVDB
Duque (2002) THERAPEUTICS failure: Portuguese Cohort Unpublished 1e-128 104
104RT
316
212PR
104RT
32 HIVDB
Duque (2002) HUMAN immunodeficiency virus type 1 M36TV insertion in protease sequence Unpublished 1e-78  
2
2PR
0 Pending
Dutta Choudhury (2009) Antiretroviral drug resistance mutations in the reverse transcriptase gene of HIV-1 isolates from Northern Indian patients Unpublished 7e-169  
3
3RT
0 Pending
Dvali (2010) Characterization of HIV-1 subtypes and drug resistance mutations among individuals infected with HIV in Georgia J. Med. Virol. 84 (7), 1002-1008 (2012) 4e-58 32
32PR
32RT
32
32PR
100 HIVDB
Dykes (2004) DETECTION of Minority Drug-Resistant Variants of HIV-1 During Virologic Failure of Zidovudine (ZDV), Lamivudine (3TC), and Indinavir (IDV) Unpublished 0  
270
270PR
212RT
0 Evolution/quasispecies study
Dzissyuk (2011) Direct Submission Submitted (16-DEC-2010) Science, Republican Center 3e-60  
47
47PR
0 Unpublished
Dzissyuk (2013) Analysis of gene pol of HIV-1 variants circulating in Kazakhstan Unpublished 0  
127
102PR
42RT
0 need annotation
Eberle (2008) SEQUENCE of a HIV-1 Subtype F that is underquantified by Roche COBAS TaqMan and COBAS Amplicor Virus Load Tests Unpublished 0  
1
1RT
1IN
0 Case report(s) / study subset
Eberle (2013) HIV-2 in Austria Unpublished 2e-128  
5
5IN
0 Unpublished
Edmonson (1998) EVOLUTION of a simian immunodeficiency virus pathogen J. Virol. 72 (1), 405-414 (1998) 4e-22  
1
1IN
0 Laboratory/experimental isolate
El Annaz (2010) Presence of drug resistance mutations among drug-naive patients in Morocco AIDS Res. Hum. Retroviruses (2010) In press 1e-148 59
48PR
11RT
59
48PR
11RT
100 HIVDB
El Annaz (2011) Drug Resistance Mutations in HIV Type 1 Isolates from Patients Failing Antiretroviral Therapy in Morocco AIDS Res. Hum. Retroviruses 28 (8), 944-948 (2012) 3e-180 59
39PR
20RT
59
39PR
20RT
100 HIVDB
El-Khatib (2011) Viremia and drug resistance among HIV-1 patients on antiretroviral treatment: a cross-sectional study in Soweto, South Africa AIDS 24 (11), 1679-1687 (2010) 3e-175 110
47PR
110RT
110
10PR
110RT
100 HIVDB
El-Khatib (2011) Drug resistance patterns and virus re-suppression among HIV-1 subtype C infected patients receiving non-nucleoside reverse transcriptase inhibitors in South Africa J AIDS Clin Res 2 (117) (2011) 1e-171  
7
7RT
0 Pending
Ellenberger (1997) Genetic analysis of human immunodeficiency virus in Abidjan, Ivory Coast reveals predominance of HIV type 1 subtype A and introduction of subtype G. ARHR 7e-86 20
20PR
23
23PR
86 HIVDB
Ellis (2009) Increased detection of HIV-1 drug-resistance at primary diagnosis in peripheral blood cells compared to plasma Unpublished 0  
61
58PR
6RT
0 Evolution/quasispecies study
Ellis (2011) Selection of HIV Resistance Associated with Antiretroviral Therapy (ART) Initiated due to Pregnancy and Suspended Postpartum J Acquir Immune Defic Syndr (2011) 0  
41
38PR
37RT
0 Pending
Engelbrecht (2013) The molecular characterization of HIV-1 in a Cape Town cohort investigated for HAND Unpublished 0  
43
31PR
37RT
0 need annotation
Engelbrecht (2013) HIV-1 subtypes B and C Unique Recombinant forms (URFs) and transmitted drug resistance identified in the Western Cape Province, South Africa Unpublished 2e-178  
44
37PR
13RT
0 need annotation
English (2011) Transmission of highly distinct HIV-1 variants from a single donor Unpublished 5e-174  
67
67RT
0 Case report(s) / study subset
Eremin (2010) CRF02_A/G isolated from patient on HAART with NRTIs and NNRTIs high level resistance Unpublished 1e-178  
1
1RT
0 Unpublished
Eremin (2010) Genotyping HIV-1 isolated from HIV-infected children born to HIV-infected mothers Unpublished 0  
1
1RT
0 Case report(s) / study subset
Eron (1998) RESISTANCE of HIV-1 to antiretroviral agents in blood and seminal plasma: implications for transmission AIDS 12 (15), F181-F189 (1998) 1e-130  
59
59PR
59RT
0 Pending
Escobar (2012) Transmitted drug-resistance in antiretroviral-naive HIV-infected population in El Salvador Unpublished 0 73
71PR
73RT
73
48PR
58RT
100 HIVDB
Escoto-Delgadillo (2007) DRUG-RESISTANCE mutations in antiretroviral-naive patients with established HIV-1 infection in Mexico HIV Med. 6 (6), 403-409 (2005) 3e-59 7
7RT
46
46PR
15 HIVDB
Eshleman (2001) IMPACT of human immunodeficiency virus type 1 (hiv-1) subtype on women receiving single-dose nevirapine prophylaxis to prevent hiv-1 vertical transmission (hiv network for prevention trials 012 study) J. Infect. Dis. 184 (7), 914-917 (2001) 1e-110 102
102PR
102RT
102
102PR
102RT
100 HIVDB
Eshleman (2001) ANALYSIS of human immunodeficiency virus type 1 drug resistance in children receiving nucleoside analogue reverse-transcriptase inhibitors plus nevirapine, nelfinavir, or ritonavir (Pediatric AIDS Clinical Trials Group 377) J. Infect. Dis. 183 (12), 1732-1738 (2001) 1e-129 229
229PR
229RT
229
229PR
229RT
100 HIVDB
Eshleman (2002) SURVIVAL of Ugandan infants with subtype A and D HIV-1 infection (HIVNET 012) J. Acquir. Immune Defic. Syndr. 31 (3), 327-330 (2002) 1e-112 54
54PR
54RT
54
54PR
54RT
100 HIVDB
Eshleman (2003) USE of uracil N-glycosylase (UNG) negative Escherichia coli to clone dUTP-containing HIV-1 DNA generated using a commercial HIV-1 genotyping system Unpublished 0  
20
20PR
20RT
0 Laboratory/experimental isolate
Eshleman (2004) CHARACTERIZATION of nevirapine resistance mutations in women with subtype A vs. D HIV-1 6-8 weeks after single-dose nevirapine (HIVNET 012) J. Acquir. Immune Defic. Syndr. 35 (2), 126-130 (2004) 0 178
178PR
178RT
178
178PR
178RT
100 HIVDB
Eshleman (2004) PERFORMANCE of the Celera Diagnostics ViroSeq HIV-1 Genotyping System for Sequence-Based Analysis of Diverse Human Immunodeficiency Virus Type 1 Strains J. Clin. Microbiol. 42 (6), 2711-2717 (2004) 0 124
124PR
124RT
124
124PR
124RT
100 HIVDB
Eshleman (2004) COMPARISON of nevirapine (NVP) resistance in Ugandan women 7 days vs. 6-8 weeks after single-dose NVP prophylaxis: HIVNET 012 AIDS Res. Hum. Retroviruses 20 (6), 595-599 (2004) 0 76
76PR
76RT
78
78PR
78RT
97 HIVDB
Eshleman (2005) LIMITED Evolution in the HIV Type 1 pol Region among Acute Seroconverters in Pune, India AIDS Res. Hum. Retroviruses 21 (1), 93-97 (2005) 0 29
29PR
29RT
33
33PR
33RT
87 HIVDB
Eshleman (2005) NEVIRAPINE (NVP) Resistance in Women with HIV-1 Subtype C, Compared with Subtypes A and D, after the Administration of Single-Dose NVP J. Infect. Dis. 192 (1), 30-36 (2005) 0 65
65PR
65RT
67
58PR
67RT
97 HIVDB
Eshleman (2005) DISTINCT patterns of emergence and fading of K103N and Y181C in women with subtype A vs. D after single-dose nevirapine: HIVNET 012 J. Acquir. Immune Defic. Syndr. 40 (1), 24-29 (2005) 0  
81
80PR
81RT
0 Evolution/quasispecies study
Eshleman (2006) PHENOTYPIC drug resistance patterns in subtype A HIV-1 clones with non-nucleoside reverse transcriptase (NNRTI) resistance mutations AIDS Res. Hum. Retroviruses (2005) In press 0 35
35PR
35RT
35
31PR
35RT
100 HIVDB
Eshleman (2006) NEVIRIPINE Resistance in Malawian Infants AIDS. 2005 Dec 2;19(18):2167-9. 0  
78
54PR
78RT
0 Pending
Eshleman (2007) ANTIRETROVIRAL drug resistance, HIV-1 tropism, and HIV-1 subtype among men who have sex with men with recent HIV-1 infection AIDS 21 (9), 1165-1174 (2007) 0 195
195PR
195RT
195
186PR
195RT
100 HIVDB
Eshleman (2008) HIV-1 variants with nevirapine resistance mutations are rarely detected in antiretroviral drug naive African women with subtypes A, C, and D AIDS Res. Hum. Retroviruses (2007) In press 0 198
198PR
198RT
198
82PR
198RT
100 HIVDB
Eshleman (2009) Analysis of pol integrase sequences in diverse HIV type 1 strains using a prototype genotyping assay AIDS Res. Hum. Retroviruses 25 (3), 343-345 (2009) 1e-167 110
110IN
120
120IN
91 HIVDB
Eshleman (2009) Antiretroviral drug susceptibility among drug-naive adults with recent HIV infection in Rakai, Uganda AIDS 27 (7), 845-852 (2009) 1e-169 104
104PR
104RT
104
82PR
54RT
100 HIVDB
Eshleman (2011) Analysis of Genetic Linkage of HIV From Couples Enrolled in the HIV Prevention Trials Network 052 Trial J. Infect. Dis. (2011) In press 0  
226
48PR
226RT
0 Evolution/quasispecies study
Espinosa (2002) INTERSUBTYPE BF recombinants of HIV-1 in a population of injecting drug users in Argentina J. Acquir. Immune Defic. Syndr. 36 (1), 630-636 (2004) 1e-102 21
21PR
21RT
21
21PR
21RT
100 HIVDB
Esteves (2007) FULL-LENGTH HIV-1 subtype G molecular clone Unpublished 0  
1
1PR
1RT
1IN
0 Case report(s) / study subset
Etiebet (2011) Tenofovir Disoproxil Fumarate based regimens associated with less nucleoside reverse transcriptase inhibitors drug resistance mutations in Nigerian patients failing first-line anti-retroviral therapy Unpublished 2e-57  
40
40PR
0 Pending
Etienne (2012) Non-invasive follow-up of simian immunodeficiency virus infection in wild-living non-habituated western lowland gorillas in Cameroon J. Virol. (2012) In press 2e-25  
6
6IN
0 Pending
Eyer-Silva (2002) REMISSION of HIV-associated myelopathy after initiation of lopinavir in a patient with extensive previous exposure to highly active antiretroviral therapy AIDS 16 (17), 2367-2369 (2002) 4e-47  
1
1PR
0 Case report(s) / study subset
Eyer-Silva (2006) MOLECULAR epidemiology of HIV-1 infection in a small Brazilian county: usefulness of envelope and polymerase sequences to epidemiologic studies J. Acquir. Immune Defic. Syndr. 41 (5), 664-670 (2006) 1e-136  
55
16PR
54RT
0 ARV Rx and/or other data are N/A
Eyer-Silva (2007) MOLECULAR Epidemiology of HIV Type 1 in Inner Rio De Janeiro State, Brazil AIDS Res. Hum. Retroviruses 23 (2), 303-308 (2007) 0 24
24PR
24RT
79
31PR
78RT
30 HIVDB
Eyer-Silva (2007) Molecular Epidemiology of HIV Type 1 in Inner Rio De Janeiro State, Brazil AIDS Res. Hum. Retroviruses 23 (2), 303-308 (2007) 3e-57 2
2PR
2RT
2
2PR
100 HIVDB
Eyer-Silva (2008) AUTOCHTHONOUS horizontal transmission of a CRF02_AG strain revealed by a human immunodeficiency virus type 1 diversity survey in a small city in inner state of Rio de Janeiro, Southeast Brazil Mem. Inst. Oswaldo Cruz 102 (7), 809-815 (2007) 0 32
32PR
32RT
32
31PR
1RT
100 HIVDB
Eymard-Duvernay (2013) Extraordinary Heterogeneity of Virological Outcomes in Patients Receiving HAART and Monitored with the World Health Organization (WHO) Public Health Approach in sub-Saharan Africa and south-east Asia Unpublished 0  
263
25PR
246RT
0 Pending
Eyre (2006) MULTIPLE drug resistance mutations in human immunodeficiency virus in semen but not blood of a man on antiretroviral therapy Urology 55 (4), 591 (2000) 6e-59  
35
35PR
0 Case report(s) / study subset
Eyzaguirre (2006) FIRST Molecular Surveillance Report of HIV Type 1 in Injecting Drug Users And Female Sex Workers along The U.S.-Mexico Border AIDS Res. Hum. Retroviruses 23 (2), 331-334 (2007) 1e-149  
11
10PR
11RT
0 Case report(s) / study subset
Eyzaguirre (2007) Genetic characterization of HIV-1 strains circulating in Kazakhstan J. Acquir. Immune Defic. Syndr. 46 (1), 19-23 (200 0 82
82PR
82RT
6IN
88
86PR
6RT
6IN
93 HIVDB
Eyzaguirre (2011) Low HIV-1 viral load associated with increased prevalence of defective proviruses in Natural Viral Suppressors Unpublished 0  
46
36PR
46RT
46IN
0 Unpublished
Eyzaguirre (2011) Molecular Epidemiology of Human Immunodeficiency Virus-Infected Individuals in Paraguay Unpublished 0  
26
15PR
26RT
26IN
0 ARV Rx and/or other data are N/A
Eyzaguirre (2011) Characterization of Acute HIV-1 Infection in High-Risk Nigerian Populations and the comparison with Acute HIV-1 Subtype B Infection Unpublished 0  
14
2PR
14RT
14IN
0 Pending
Falloon (2000) COMBINATION therapy with amprenavir, abacavir, and efavirenz in human immunodeficiency virus (HIV)-infected patients failing a protease-inhibitor regimen: pharmacokinetic drug interactions and antiviral activity Clin. Infect. Dis. 30 (2), 313-318 (2000) 1e-118 40
20PR
20RT
40
20PR
20RT
100 HIVDB
Fang (2000) GENETIC Variability of the HIV-1 Sequences from Plasma and Cervical Compartments Unpublished 1e-164  
42
42PR
42RT
18IN
0 Evolution/quasispecies study
Fang (2001) ANALYSIS of transition from long-term nonprogressive to progressive infection identifies sequences that may attenuate HIV type 1 AIDS Res. Hum. Retroviruses 17 (15), 1395-1404 (2001) 1e-163  
10
10PR
10RT
10IN
0 Case report(s) / study subset
Fang (2004) LONG-TERM Survivors in Nairobi: Complete HIV-1 RNA Sequences and Immunogenetic Associations J. Infect. Dis. 190 (4), 697-701 (2004) 0 7
7PR
7RT
7IN
7
7PR
7RT
7IN
100 HIVDB
Fang (2002) PCR-MEDIATED recombination: a general method applied to construct chimeric infectious molecular clones of plasma-derived HIV-1 RNA Nat. Med. 5 (2), 239-242 (1999) 1e-163  
2
2PR
2RT
2IN
0 Laboratory/experimental isolate
Fang (2003) RECOMBINATION following superinfection by HIV-1 AIDS 18 (2), 153-159 (2004) 0  
3
3PR
3RT
3IN
0 Case report(s) / study subset
Fang (1995) UNIQUE insertion sequence and pattern of CD4 expression in variants selected with immunotoxins from human immunodeficiency virus type 1-infected T cells J. Virol. 69 (1), 75-81 (1995) 1e-164  
1
1PR
1RT
1IN
0 Laboratory/experimental isolate
Farrar (1991) CHARACTERISATION of a series of human immunodeficiency virus isolates derived sequentially from a single patient J. Med. Virol. 34 (2), 104-113 (1991) 1e-163  
1
1PR
1RT
1IN
0 Case report(s) / study subset
Federico (1989) BIOLOGIC and molecular characterization of producer and nonproducer clones from HUT-78 cells infected with a patient HIV isolate AIDS Res. Hum. Retroviruses 5 (4), 385-396 (1989) 1e-165  
1
1PR
1RT
1IN
0 Laboratory/experimental isolate
Feng (2013) The rapidly expanding CRF01_AE epidemic in China is driven by multiple lineages of HIV-1 viruses introduced in the 1990s AIDS 27 (11), 1793-1802 (2013) 0  
75
75RT
75IN
0 Pending
Fernandez (2006) FITNESS Landscape of Human Immunodeficiency Virus Type 1 Protease Quasispecies J. Virol. 81 (5), 2485-2496 (2007) 4e-60  
306
306PR
0 Evolution/quasispecies study
Fernandez-Garcia (2008) DEVELOPMENT of a Panel of Well-Characterized Human Immunodeficiency Virus Type 1 Isolates from Newly Diagnosed Patients Including Acute and Recent Infections AIDS Res. Hum. Retroviruses 25 (1), 93-102 (2009) 0  
14
3PR
14RT
14IN
0 Case report(s) / study subset
Fernandez-Garcia (2009) Near full-length genome characterization of a newly identified HIV type 1 subtype F variant circulating in St. Petersburg, Russia AIDS Res. Hum. Retroviruses 25 (11), 1187-1191 (20 0 2
2PR
2RT
2IN
2
2RT
2IN
100 HIVDB
Fernandez-Garcia (2010) Identification of a new HIV-1 circulating BF intersubtype recombinant form (CRF47_BF) in Spain AIDS Res. Hum. Retroviruses (2010) In press 0 4
4PR
4RT
2IN
7
4PR
7RT
2IN
57 HIVDB
Fernandez-Garcia (2012) The analysis of near full-length genome sequences of HIV-1 subtype A viruses from Russia supports the monophyly of major intrasubtype clusters AIDS Res. Hum. Retroviruses (2012) In press 0 10
10PR
10RT
10IN
10
4PR
10RT
10IN
100 HIVDB
Ferradini (2012) High efficacy of lopinavir/r-based second-line antiretroviral treatment after 24 months of follow up at ESTHER/Calmette Hospital in Phnom Penh, Cambodia J Int AIDS Soc 14, 14 (2011) 1e-57 1
1PR
1
1PR
100 HIVDB
Ferrari (2004) HLA-A and -B allele expression and ability to develop anti-Gag cross-clade responses in subtype C HIV-1 infected Ethiopians Hum. Immunol. 65 (6), 648-659 (2004) 8e-08  
11
11PR
0 Gene fragment(s)
Ferreira (2008) Molecular characterisation of newly identified HIV-1 infections in Curitiba, Brazil: preponderance of clade C among males with recent infections. Mem Ins Oswaldo Cruz 0 37
37PR
37RT
37
31PR
12RT
100 HIVDB
Ferreira (2011) Moderate prevalence of transmitted drug resistance and high HIV-1 genetic diversity in patients from Mato Grosso State, Central Western Brazil J. Med. Virol. 83 (8), 1301-1307 (2011) 1e-173 82
82PR
82RT
82
79PR
16RT
100 HIVDB
Ferreira (2010) Prevalence of primary drug resistance-associated mutations among HIV type 1 vertically Infected children in Belo Horizonte, Brazil AIDS Res. Hum. Retroviruses 26 (2), 229-232 (2010) 0 40
40PR
40RT
40
12PR
40RT
100 HIVDB
Finzi (1997) IDENTIFICATION of a reservoir for HIV-1 in patients on highly active antiretroviral therapy Science 278 (5341), 1295-1300 (1997) 1e-124  
12
12PR
12RT
0 Evolution/quasispecies study
Fischer (2012) Distinct Evolutionary Pressures Underlie Diversity in Simian Immunodeficiency Virus and Human Immunodeficiency Virus Lineages J. Virol. 86 (24), 13217-13231 (2012) 0  
24
24RT
24IN
0 Pending
Fischetti (2003) MOLECULAR epidemiology of HIV in Ghana: dominance of CRF02_AG J. Med. Virol. 73 (2), 158-166 (2004) 4e-85  
235
235RT
0 Gene fragment(s)
Fish (2010) Natural polymorphisms of integrase among HIV type 1-infected South African patients AIDS Res. Hum. Retroviruses 26 (4), 489-493 (2010) 1e-163 73
73IN
73
73IN
100 HIVDB
Fisher (2012) Deep sequencing reveals minor protease resistance mutations in patients failing a protease inhibitor regimen J. Virol. 86 (11), 6231-6237 (2012) 2e-176  
7
5PR
5RT
0 Case report(s) / study subset
Fitzgibbon (1991) IN vivo prevalence of azidothymidine (AZT) resistance mutations in an AIDS patient before and after AZT therapy AIDS Res. Hum. Retroviruses 7 (3), 265-269 (1991) 3e-56  
18
18RT
0 Case report(s) / study subset
Fitzgibbon (1993) HUMAN immunodeficiency virus type 1 pol gene mutations in an AIDS patient treated with multiple antiretroviral drugs J. Virol. 67 (12), 7271-7275 (1993) 9e-94  
23
23RT
0 Case report(s) / study subset
Fitzgibbon (1993) A new type of G-->A hypermutation affecting human immunodeficiency virus AIDS Res. Hum. Retroviruses 9 (9), 833-838 (1993) 6e-67  
2
2RT
0 Case report(s) / study subset
Fitzgibbon (1993) HUMAN immunodeficiency virus type 1 pol gene mutations which cause decreased susceptibility to 2',3'-dideoxycytidine Antimicrob. Agents Chemother. 36 (1), 153-157 (1992) 8e-54 17
17RT
17
17RT
100 HIVDB
Fitzgibbon (2001) EMERGENCE of drug resistance mutations in a group of HIV-infected children taking nelfinavir-containing regimens AIDS Res. Hum. Retroviruses 17 (14), 1321-1328 (2001) 1e-126 51
28PR
23RT
51
28PR
23RT
100 HIVDB
Flaherty (1997) MOLECULAR and biological characterization of a neurovirulent molecular clone of simian immunodeficiency virus J. Virol. 71 (8), 5790-5798 (1997) 5e-99  
1
1PR
1RT
1IN
0 Laboratory/experimental isolate
Fleury (2011) Drug resistance mutations in HIV-1 isolates from naive patients eligible for first line ART in JJ Hospital, Mumbai, India AIDS Res. Hum. Retroviruses (2011) In press 5e-50 5
5PR
5
5PR
100 HIVDB
Fleury (2012) Molecular characterization of HIV-1 in Brazzaville, Republic of Congo, and first data on resistance to antiretroviral drugs AIDS Res. Hum. Retroviruses (2012) In press 4e-51 14
14PR
14
14PR
100 HIVDB
Florea (2012) HIV transmitted drug resistance in Romania 2007-2010 Unpublished 0 65
65PR
65RT
65
1PR
65RT
100 HIVDB
Flores (1999) HIV-1 subtype F in single and dual infections in Puerto Rico: A potential sentinel site for monitoring novel genetic HIV variants in North America Emerging Infect. Dis. 5 (3), 481-483 (1999) 1e-130 19
19PR
19
19PR
100 HIVDB
Fogel (2012) Analysis of nevirapine resistance in HIV-infected infants who received extended nevirapine or nevirapine/zidovudine prophylaxis AIDS. 2011 Apr 0  
61
12PR
61RT
0 Pending
Fogel (2012) Emergence of nevirapine resistance in HIV-infected infants is associated with exposure to extended daily nevirapine prophylaxis and post-partum initiation of maternal HIV treatment Unpublished 0  
1
1RT
0 Unpublished
Fokam (2012) Drug resistance among drug-naive and first-line antiretroviral treatment-failing children in Cameroon Pediatr. Infect. Dis. J. 30 (12), 1062-1068 (2011) 0 80
80PR
80RT
80
8PR
78RT
100 HIVDB
Fomsgaard (1991) A highly divergent proviral DNA clone of SIV from a distinct species of African green monkey Virology 182 (1), 397-402 (1991) 1e-113 2
2PR
2RT
2IN
2
2PR
2RT
2IN
100 HIVDB
Fomsgaard (2008) FULL-LENGTH Characterization of A1/D Intersubtype Recombinant Genomes from a Therapy-Induced HIV Type 1 Controller during Acute Infection and His Noncontrolling Partner AIDS Res. Hum. Retroviruses 24 (3), 463-472 (2008) 0  
2
2PR
2RT
2IN
0 Case report(s) / study subset
Fonjungo (2000) HUMAN immunodeficiency virus type 1 group m protease in cameroon: genetic diversity and protease inhibitor mutational features J. Clin. Microbiol. 40 (3), 837-845 (2002) 1e-121 110
110PR
111
111PR
99 HIVDB
Foster (2012) Novel HIV-1 recombinants circulating in the United Kingdom among men who have sex with men Unpublished 0  
6
4PR
6RT
6IN
0 Case report(s) / study subset
Fourati (2012) E138K and M184I Mutations in HIV-1 Reverse Transcriptase Emerge Concomitantly as a result of APOBEC3 Editing in the Absence of Drug Exposure Unpublished 7e-174 326
326RT
326
326RT
100 HIVDB
Fourati (2014) Differential impact of APOBEC3-driven mutagenesis on HIV evolution in diverse anatomical compartments Unpublished 4e-64  
16
16PR
0 Pending
Frahm (2006) INCREASED Sequence Diversity Coverage Improves Detection of HIV-Specific T Cell Responses J. Immunol. 179 (10), 6638-6650 (2007) 0  
8
6PR
8RT
8IN
0 Case report(s) / study subset
Franchini (1996) MOLECULAR and biological characterization of a replication competent human immunodeficiency type 2 (HIV-2) proviral clone Proc. Natl. Acad. Sci. U.S.A. 86 (7), 2433-2437 (1989) 0.017  
1
1RT
0 Laboratory/experimental isolate
Franchini (2004) SEQUENCE of simian immunodeficiency virus and its relationship to the human immunodeficiency viruses Nature 328 (6130), 539-543 (1987) 0  
1
1RT
1IN
0 Laboratory/experimental isolate
Frange (2008) NEW and Old Complex Recombinant HIV-1 Strains Among Patients with Primary Infection in 1996-2006 in France: the French ANRS CO06 Primo Cohort Study Unpublished 0  
2
2RT
2IN
0 Case report(s) / study subset
Frange (2012) Recent HIV-1 Infection Contributes to the Viral Diffusion over the French Territory with a Recent Increasing Frequency PLoS ONE 7 (2), E31695 (2012) 0 193
4PR
193RT
193
4PR
190RT
100 HIVDB
Freitas (2012) Novel multi-region hybridization assay for the identification of the most prevalent genetic forms of the human immunodeficiency virus type 1 (HIV-1) circulating in Portugal AIDS Res. Hum. Retroviruses (2012) In press 0  
3
3RT
3IN
0 ARV Rx and/or other data are N/A
Frenkel (2002) MULTIPLE Viral Genetic Analyses Detect Low-Level Human Immunodeficiency Virus Type 1 Replication during Effective Highly Active Antiretroviral Therapy J. Virol. 77 (10), 5721-5730 (2003) 1e-135  
979
777PR
801RT
0 Evolution/quasispecies study
Frenkel (2003) DRUG-RESISTANT mutants of human immunodeficiency virus type 1 persist at higher concentrations in peripheral blood mononuclear cells compared to plasma and are detected at a higher rate by OLA compared to consensus sequencing Unpublished 1e-136  
107
57PR
99RT
0 ARV Rx and/or other data are N/A
Frentz (2012) Increase in transmitted resistance to non-nucleoside reverse transcriptase inhibitors among newly diagnosed HIV-1 infections in Europe Unpublished 2e-52 716
716PR
716RT
716
716PR
100 HIVDB
Frentz (2013) Limited cross-border infections in patients newly diagnosed with HIV in Europe Retrovirology 10, 36 (2013) 3e-176 585
582PR
585RT
585
523PR
252RT
100 HIVDB
Fujisaki (2009) An 11-Year Surveillance of HIV Type 1 Subtypes in Nagoya, Japan AIDS Res. Hum. Retroviruses 25 (1), 15-21 (2009) 1e-58 126
126PR
126RT
126
126PR
100 HIVDB
Fukasawa (1999) SEQUENCE of simian immunodeficiency virus from African green monkey, a new member of the HIV/SIV group Nature 333 (6172), 457-461 (1988) 1e-109 1
1PR
1RT
1IN
1
1RT
1IN
100 HIVDB
Fumin (2002) CLONING and Characterization of a Virtually Full-Length HIV-1 Genome of a Prevalent Subtype B-Thai Strain in Central China Unpublished 1e-162  
1
1PR
1RT
1IN
0 Case report(s) / study subset
Fun (2012) Mutation Q95K enhances N155H-mediated integrase inhibitor resistance and improves viral replication capacity J. Antimicrob. Chemother. 65 (11), 2300-2304 (2010 1e-164  
5
5IN
0 Pending
Gafarova (2008) Direct Submission Submitted (19-NOV-2008) Biotechnology, The D.I. Iv 1e-166  
44
1PR
43IN
0 Unpublished
Gafarova (2009) The sequence of fragment of HIV-1 subtype G pol gene from Russia patient 0110 Unpublished 1e-177  
2
1RT
1IN
0 Case report(s) / study subset
Gafarova (2009) Full sequence of HIV-1 subtype G protease gene, isolated from Russia patient 104 Unpublished 5e-49  
1
1PR
0 Case report(s) / study subset
Galkin (2004) FULL-LENGTH Genomic Sequencing and Analysis of Four HIV Type 1 Subtype B Isolates Circulating in the Territory of Russia AIDS Res. Hum. Retroviruses 22 (11), 1192-1197 (2006) 0 4
4PR
4RT
4IN
4
3PR
4RT
4IN
100 HIVDB
Galkin (2006) SEQUENCING and analysis of full-length HIV-1 CRF06_cpx isolate from Russia Unpublished 0 1
1PR
1RT
1IN
1
1RT
1IN
100 HIVDB
Galkin (2009) The study of long-term HAART treatment effect for resistance-connected alterations in HIV-1 subtype B genes of 4 Austrian IDU patients Unpublished 0  
3
2PR
3RT
3IN
0 Case report(s) / study subset
Gall (2014) Complete Genome Sequence of the WHO International Standard for HIV-1 RNA determined by Deep Sequencing Unpublished 0  
1
1PR
1RT
1IN
0 Laboratory/experimental isolate
Gallant (2005) EARLY Virologic Non-Response to Tenofovir, Abacavir, and Lamivudine in HIV-Infected Antiretroviral Naive Subjects J. Infect. Dis. (2005) In press 1e-173 41
41PR
41RT
41
41PR
41RT
100 HIVDB
Galli (2007) RECOMBINATION analysis and structure prediction show correlation between breakpoint clusters and RNA hairpins in the pol gene of human immunodeficiency virus type 1 unique recombinant forms J. Gen. Virol. 89 (PT 12), 3119-3125 (2008) 1e-133  
32
31PR
4RT
0 Pending
Galluzzo (2012) Antiretroviral resistance mutations in untreated pregnant women with HIV infection in Uganda and Rwanda AIDS Res. Hum. Retroviruses 23 (11), 1449-1451 (20 1e-60 59
59PR
59
59PR
100 HIVDB
Gandhi (2008) ROLE of APOBEC3G/F-mediated hypermutation in the control of human immunodeficiency virus type 1 in elite suppressors J. Virol. 82 (6), 3125-3130 (2008) 0.027  
1
1IN
0 Gene fragment(s)
Gao (2001) RECOMBINATION in human immunodefeciency virus type 2 Unpublished 1e-100  
1
1RT
1IN
0 Laboratory/experimental isolate
Gao (2003) COMPLETE genomes of HIV-1 subtype C viruses in South Africa Unpublished 0  
2
2PR
2RT
2IN
0 Laboratory/experimental isolate
Gao (1999) ORIGIN of HIV-1 in the chimpanzee Pan troglodytes troglodytes Nature 397 (6718), 436-441 (1999) 1e-155 1
1PR
1RT
1IN
1
1PR
1RT
1IN
100 HIVDB
Gao (1996) MOLECULAR cloning and analysis of functional envelope genes from human immunodeficiency virus type 1 sequence subtypes A through G. The WHO and NIAID Networks for HIV Isolation and Characterization J. Virol. 70 (3), 1651-1667 (1996) 1e-162 2
2PR
2RT
2IN
2
2PR
2RT
2IN
100 HIVDB
Gao (1996) THE heterosexual human immunodeficiency virus type 1 epidemic in Thailand is caused by an intersubtype (A/E) recombinant of African origin J. Virology 70 (10), 7013-7029 (1996) 1e-164 2
2PR
2RT
2IN
2
2PR
2RT
2IN
100 HIVDB
Gao (1998) AN isolate of human immunodeficiency virus type 1 originally classified as subtype I represents a complex mosaic comprising three different group M subtypes (A, G, and I) J. Virol. 72 (12), 10234-10241 (1998) 1e-161 1
1PR
1RT
1IN
1
1PR
1RT
1IN
100 HIVDB
Gao (1998) A comprehensive panel of near-full-length clones and reference sequences for non-subtype B isolates of human immunodeficiency virus type 1 J. Virol. 72 (7), 5680-5698 (1998) 1e-166 8
8PR
8RT
8IN
8
8PR
8RT
8IN
100 HIVDB
Gao (2001) MOLECULAR characterization of a highly divergent HIV type 1 isolate obtained early in the AIDS epidemic from the Democratic Republic of Congo AIDS Res. Hum. Retroviruses 17 (12), 1217-1222 (2001) 1e-166 1
1PR
1RT
1IN
1
1PR
1RT
1IN
100 HIVDB
Gao (2001) EVIDENCE of two distinct subsubtypes within the HIV-1 subtype A radiation AIDS Res. Hum. Retroviruses 17 (8), 675-688 (2001) 1e-164 6
5PR
5RT
6IN
10
9PR
6RT
6IN
60 HIVDB
Gao (1992) HUMAN infection by genetically diverse SIVSM-related HIV-2 in west Africa Nature 358 (6386), 495-499 (1992) 5e-66 3
3RT
16
16RT
16IN
18 HIVDB
Gao (1993) GENETIC typing of HIV-2 from a Senegalese/German heterosexual transmission AIDS Res. Hum. Retroviruses 9 (7), 703-704 (1993) 2e-64  
2
2RT
2IN
0 Case report(s) / study subset
Gao (1994) GENETIC diversity of human immunodeficiency virus type 2: evidence for distinct sequence subtypes with differences in virus biology J. Virol. 68 (11), 7433-7447 (1994) 1e-111 2
2RT
6
6RT
4IN
33 HIVDB
Garaev (2006) 5' region of HIV-1 G subtype pol gene Unpublished 1e-163  
79
3PR
79RT
0 Pending
Garaev (2007) DIRECT Submission Submitted (08-NOV-2006) Biotechnology, The D.I. Ivanovsky In 1e-161  
13
2PR
12RT
0 Unpublished
Garcia-Arriaza (2007) CHARACTERIZATION of minority subpopulations in the mutant spectrum of HIV-1 quasispecies by successive specific amplifications Virus Res. 129 (2), 123-134 (2007) 2e-50  
3
3PR
0 Case report(s) / study subset
Garcia-Bujalance (2005) COMPARISON between Sequence Analysis and a Line Probe Assay for Testing Genotypic Resistance of Human Immunodeficiency Virus Type 1 to Antiretroviral Drugs J. Clin. Microbiol. 43 (8), 4186-4188 (2005) 1e-123 94
40PR
54RT
94
40PR
54RT
100 HIVDB
Garcia-Lerma (2001) INCREASED ability for selection of zidovudine resistance in a distinct class of wild-type HIV-1 from drug-naive persons Proc. Natl. Acad. Sci. U.S.A. 98 (24), 13907-13912 (2001) 5e-89  
7
7RT
0 Case report(s) / study subset
Garcia-Lerma (2004) TRANSMITTED Human Immunodeficiency Virus Type 1 Carrying the D67N or K219Q/E Mutation Evolves Rapidly to Zidovudine Resistance In Vitro and Shows a High Replicative Fitness in the Presence of Zidovudine J. Virol. 78 (14), 7545-7552 (2004) 1e-142  
6
6RT
0 Case report(s) / study subset
Garcia-Vallejo (2009) Molecular epidemiology of Human immunodeficiency virus (HIV-1) antiviral resistance in isolates from patient of Colombian Caribbean Region Unpublished 0  
116
57PR
59RT
0 Unpublished
Garcia-Vallejo (2009) First Report of Human Immunodeficiency Virus type 2 (HIV-2) Infection in the Colombian Caribbean Region Unpublished 0  
3
3RT
0 Unpublished
Garrido (2009) Integrase variability and susceptibility to HIV integrase inhibitors: impact of subtypes, antiretroviral experience and duration of HIV infection J. Antimicrob. Chemother. 65 (2), 320-326 (2010) 1e-166 418
418IN
418
418IN
100 HIVDB
Garrido (2010) Dynamics in the selection of resistance mutations in HIV patients failing Raltegravir and following its discontinuation Unpublished 1e-166  
53
53IN
0 Unpublished
Garrido (2012) Broad Phenotypic Cross-Resistance to Elvitegravir in HIV-Infected Patients Failing on Raltegravir-Containing Regimens Antimicrob. Agents Chemother. 56 (6), 2873-2878 (2 1e-166 61
61IN
62
62IN
98 HIVDB
Garriga (2010) HIV-1 reverse transcriptase thumb subdomain polymorphisms associated with virological failure to nucleoside drug combinations J. Antimicrob. Chemother. 64 (2), 251-258 (2009) 0  
153
76PR
147RT
0 Pending
Gashnikova (2011) Biological and Genetic Characterization of HIV-1 Strains Circulating in Siberia, Russia Unpublished 1e-176  
30
10PR
29RT
0 Unpublished
Gaspareto (2012) Genetic diversity and primary resistance among HIV-1-positive patients from Maringa, Parana, Brazil. Rev Inst Med Trop Sao Paulo 1e-51 14
14PR
14
14PR
100 HIVDB
Gaspareto (2012) Study of the genetic diversity and of the primary resistance rates in HIV-1 positive individuals in surveillance at the Division of Specialized Care in STD/AIDS in the city of Maringa, Parana Unpublished 6e-61 31
31PR
31
31PR
100 HIVDB
Gatanaga (1999) ACTIVE HIV-1 redistribution and replication in the brain with HIV encephalitis Arch. Virol. 144 (1), 29-43 (1999) 1e-52  
261
261RT
0 Evolution/quasispecies study
Gatanaga (1999) ANTI-HIV effect of saquinavir combined with ritonavir is limited by previous long-term therapy with protease inhibitors AIDS Res. Hum. Retroviruses 15 (17), 1493-1498 (1999) 1e-126 15
15PR
15
15PR
100 HIVDB
Gatanaga (2000) DISCORDANCE between plasma- and PBMC-derived HIV-1 genotypes on protease inhibitor resistance Unpublished 1e-130  
70
70PR
0 ARV Rx and/or other data are N/A
Gatanaga (2011) Drug-resistant HIV-1 prevalence in patients newly diagnosed with HIV/AIDS in Japan Antiviral Res. 75 (1), 75-82 (2007) 0 2320
2253PR
2101RT